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Abstract 
Macromoleclar protein complexes comprise a critical class of biomolecules unique in both their 
importance in biology and their relative impenetrability to detailed structural probes. 
Nanoelectrospray coupled to ion mobility-mass spectrometry (nESI-IM-MS) is an emerging tool 
for determining size and structure of protein complexes. However, its usefulness in such 
endeavors is largely dependent on the ability to accurately measure and correlate both intact 
assemblies and their protein building blocks in the gas phase to biologically-relevant structures 
in solution. Previous data have indicated that protein complex charge state has a demonstrated, 
yet currently unclear, influence on the dissociation pathways available to complexes upon 
collisional activation. Here, experiments designed to evaluate many different methods for ion 
charge state manipulation are described in the context of their potential applications in structural 
biology. In addition, the charge state-dependent mechanisms by which the building blocks of 
protein complexes are revealed via collisional activation in the gas phase are studied in detail, 
uncovering new intermediates and predicative correlations.     
Following a comprehensive introductory chapter, Chapter 2 describes a detailed set of 
experiments aimed at evaluating the relative merits of different charge manipulation protocols 
for protein complex structure analysis. Gas-phase methods, such as ion-neutral chemistry 
performed in the source region of the instrument, are found to provide a superior ability to 
reduce protein charge without leading to unwanted protein unfolding. In Chapter 3, the 
dissociation pathways of two protein complexes that take near-identical product ion formation 
xviii	  	  
pathways when high charge states are considered, are studied in detail revealing the role of 
previously-unknown compact states in their dissociation mechanisms upon charge state 
reduction. In Chapter 4, ion-ion chemistry is used to rapidly screen a relatively large number of 
charge-reduced protein complexes for charge states at which collision induced dissociation and 
unfolding energy thresholds converge, producing the first relationship capable of predicting the 
amount of charge reduction necessary to shift the dissociation mechanism of collisionally 
activated protein complexes generally toward the ejection of compact, native-like product ions.  
In Chapter 5, a final summary of this work is presented, along with a projected outlook of future 
endeavors in this area. 
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Chapter 1: Introduction 
In their native states proteins most often exist as noncovalently bound multiprotein complexes 
that are critical for carrying out a wide range of critical cellular processes.1 Over the last several 
decades, tens of thousands of interactions between individual proteins have been identified;2,3 
however, the complete functional annotation of these complexes is still a major challenge.4 One 
way of overcoming the challenges inherent in broadly annotating function to the growing list of 
putative protein assemblies currently available is to develop and rapidly deploy technologies 
capable of assessing the three-dimensional structures of the identified complexes.5 Such efforts 
are currently underway,6 and will undoubtedly lead to a more detailed understanding of protein 
structure, as well as next-generation therapies for human disease.7,8  
A variety of technologies exist that are capable of probing the structure of protein 
complexes to produce high resolution, three-dimensional structure information. Two such 
technologies are X-ray diffraction (XRD)9 and nuclear magnetic resonance (NMR) 
spectroscopy.10 The former technique is often referred to as a “gold-standard” in structural 
biology, and is capable of generating structural data with resolutions less than two angstroms for 
assemblies as vast, and as complex as intact ribosomes.11,12 However, the sample requirements 
for XRD typically necessitate a large amount of high-purity, mono-disperse protein to generate 
diffraction-grade crystals.13 Meeting this requirement can be difficult, particularly if the sample 
is not easily over-expressed or is resistant to crystallization.4,6,14 Alternatively, NMR can also 
produce high-resolution structures for protein-protein complexes within a limited size range, 
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directly from solution.  Such experiments can reveal much of the dynamics and motion of protein 
assemblies in their native states,15 especially in cases where dynamic nuclear polarization (DNP) 
experiments are performed, that enable NMR measurements to be carried out in the context of 
the cellular environment.16,17 For most applications, however, high purity, high concentration 
protein samples are required to develop high-resolution structural data.18 The many limitations of 
high-resolution structural biology tools necessitates the development and implementation of new 
probes of protein structure that can be deployed more-broadly in the context of the protein 
mixtures. 
One such set of technologies is based upon mass spectrometry (MS), where analyte 
samples can be prepared at less than 10 µM concentrations, sample consumption can be reduced 
to microliter levels, and data analysis can handle mixtures containing many interacting proteins 
and small molecules.19-21 Alone MS and tandem MS (MS/MS) performed directly on intact 
protein complexes22,23 can provide stoichiometry and connectivity information; coupling MS 
with other techniques such as ion mobility (IM),24-26 chemical cross-linking (CXL),27-29 affinity 
purification (AP),30,31 hydrogen/deuterium exchange (HDX),32-35 and oxidative footprinting 
(OFP),36,37 the complete structural landscape of a protein assembly can be assessed. While it is 
important to note that many of these technologies are still under development and cannot 
individually provide the same detailed structures as XRD or NMR. By integrating structural MS 
data with protein modeling, the generation of detailed assembly structures, comparable to XRD 
or NMR, may be possible.38 Importantly, a protein structure pipeline based on MS would not be 
limited to those relatively rare proteins that are available in large amounts, at high purities, that 
are amenable to tagging and devoid of any degree of polydipersity or structural plasticity.39 
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Instead, MS technologies as part of an integrative structural biology effort may enable the 
comprehensive structural characterization on a proteome scale.4,13,40 
1.1 Mass Spectrometry in Structural Biology 
The structural information content from MS coupled technologies can be very diverse. As 
represented in Figure 1-1, the inner circle depicts the available MS technologies for studying the 
structure of multiprotein complexes, and the outer circle presents the structural information that 
can be determined from these types of analyses. HDX-MS and OFP-MS can both be used to 
measure protein-protein interface sizes between the multiprotein complex subunits as well as 
determine the folded and unfolded regions within the subunits on the residue level.41-44 AP-MS 
and CXL-MS can be used to identify specific regions of connectivity between interacting 
subunits.45-49 CXL-MS and IM-MS can both be used to measure the overall size of the 
multiprotein complex and distances between subunits, and can additionally be used to determine 
subcomplex topologies.50-54 Alone IM-MS can be used to probe overall complex shape and 
determine angles between subunits.38,50,55,56 IM-MS is unique among all these technologies in 
that it is the only method where intact, native-like protein structures are measured in the gas-
phase, which provides unique challenges to its development and application in structural 
biology.55,57,58 
All MS technologies in structural biology require the conversion of neutral, native-state 
proteins into gas-phase ions that carry useful protein structure information.  While each of the 
many structural MS techniques described above have their own instrumentation and method 
requirements, since this work deals primarily with IM-MS of intact protein complexes, the 
following discussion focuses primarily upon the instrument requirements of such experiments. 
There are two well-known ionization methods that generate large multi-protein complex ions: 
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electrospray ionization (ESI)59-62 and matrix-assisted laser desorption ionization (MALDI).63,64 
While MALDI is capable of ionizing large analytes, the high concentrations of acid in traditional 
matrices are such that native-like conformations of multiprotein complexes are difficult to 
 
Figure 1-1. Common mass spectrometry (MS) coupled technologies and their utility within the field 
of structural biology. The inner circle lists the various methods: affinity purification (AP)-MS, 
chemical cross-linking (CXL)-MS, ion mobility (IM)-MS, oxidative footprinting (OFP)-MS, and 
hydrogen/deuterium exchange (HDX)-MS. The outer circle lists the various types of structural 
information that can be measured using the available technologies, where the color and placement of 
the outer circle regions correspond to the specific method used for measurements.  For example, 
protein-protein connectivity information can be probed using either AP-MS or CXL-MS. 
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maintain.39 Furthermore, MALDI typical generates low charge state ions, which can make 
MS/MS experiments of large intact protein complex ions more difficult.65 As a result, most MS 
experiments carried out on intact multiprotein complexes utilize ESI, since it has been observed 
to better enable the preservation of native-like conformations of protein complexes in the gas-
phase.66,67 The mechanics and mechanism of ESI, and the basics of native mass spectrometry 
will be discussed in greater detail in the following sections. 
1.1.1 Nanoelectrospray Ionization (nESI) 
In 1989 the landscape of mass spectrometry changed forever when John Fenn and co-workers 
demonstrated that they could introduce large biomolecules into the gas-phase via electrospray 
ionization, eventually leading to Fenn earning part of the Nobel Prize in Chemistry in 2002.68 
Since then, ESI has evolved into a broadly-used analytical tool, enabling the ionization of 
molecules ranging from small metabolites to megadalton-scale protein complexes.69 
Furthermore, the scale of the technique has been reduced into what is known as nanoelectrospray 
ionization (nanoESI or nESI), which enables more efficient transport of ions from solution to the 
gas phase, while simultaneously reducing sample consumption and decreasing applied 
potentials.70 The basic operating principles of nESI are simple; sample is delivered to the 
interface of the mass spectrometer through a tapered capillary tube coated with a conductive 
metal (typically gold or gold-palladium alloy) as depicted in Figure 1-2a, and a high electrical 
potential is applied (0.8-2.5 kV). Under these conditions a Taylor cone is formed at the tip of the 
tapered capillary and charged analyte droplets are formed, as shown in Figure 1-2b. Flow of the 
sample solution is maintained through electroosmotic flow (EOF). The charge droplets then 
undergo a series of successive solvent evaporation-droplet fission events, where droplet fission is 
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induced by the charge on the surface of the droplet when a limiting radius is reached, as 
governed by the Rayleigh equation: 
 𝑧! = !!! 𝛾𝜀!𝑅! ! ! (1.1) 
Where  zR is the maximum charge attainable for a droplet of radius R, e is the elementary charge, 
γ is the surface tension of the solvent, and ε0 is the permittivity of the environment. When it is 
assumed that intact proteins are approximately spherical and have equal density, and are ionized 
 
Figure 1-2. Diagram depicting the operation and mechanics of nanoelectrospray ionization (nESI) 
where (a) shows the relative positioning of a tapered capillary needle containing an analyte solution 
near the entrance of a mass spectrometer. A blow up of the capillary tip and entrance (b) shows when a 
high voltage is applied relative to the capillary and entrance a Taylor cone forms and highly charged 
droplets are generated.  These charge droplets undergo a series of solvent evaporation-droplet fission 
events until only charged analyte ions remain. As described by the charge residue model (CRM) 
during the final stage of ionization (c) a single analyte molecule exists in a highly charged droplet.  As 
the droplet continues to evaporate and fission the surface charge decrease and moves closer to the 
surface of the analyte, as the last of the solvent evaporates the remaining surface charge is deposited 
onto the surface of the analyte producing a solvent-free gas-phase ion. 
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from standard nanoelectrospray conditions it has been shown that the charge state can be 
predicted by: 
 𝑧! = 0.078𝑀! ! (1.2) 
where M is the molecular mass of the protein.71 
The final stage of ionization is still an active area of research. Currently there are many 
proposed models, with the two most prominent being the charge residue model (CRM)59,60 and 
the ion evaporation model (IEM).72 For the study of intact multiprotein complexes in the gas-
phase the most widely accepted model for ion formation is CRM. As depicted is Figure 1-2c, 
during the final stages of ionization a single biomolecule is contained within a charged droplet, 
as evaporation and fission continues the droplet volume decreases until the residual droplet 
charge is deposited over the surface of the protein.59,60 Alternatively, IEM suggests that instead 
of undergoing droplet fission in the later stages of ionization, analyte ions are produced directly 
from the larger charged droplets in an evaporation-like process.72 Strong experimental evidence, 
however indicates that CRM is the dominant mechanism for large analytes, such as the 
multiprotein complexes studied here.71 
 Both CRM and IEM are mechanisms in which native-like protein conformations are 
preserved in the gas-phase, which accounts for experimental evidence validating equation 1.2.71 
However, ESI of proteins can adopt charge states distributions (CSDs) in great excess of the 
maximum CRM predicted charge.73 Such experiments are performed in non-native solvent 
conditions (to be discussed in Section 1.1.2), which disrupts protein structure to cause unfolding 
in solution.65 Because the protein exists in a different structure in solution a different model is 
used to describe the ESI process, the chain ejection model (CEM).74 In CEM, large disordered 
polymer chains, such as unfolded proteins, exist in a charged droplet. Following desolvation of 
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the large, charged droplet, fission occurs in a fashion similar to IEM, where analyte ions are 
ejected directly from the charge droplet.73,74 However, the long unfolded polymer chain cannot 
be ejected from the droplet on the same timescale as small analytes following IEM.73,74 The 
longer timescale of the ion ejection allows for charge migration to occur. As a result, the droplet 
surface charge is depleted as charge migrates to the surface of the analyte as it is ejected.74 Since 
the surface area of the unfolded analyte is must larger than the compact native-like form, the 
charge observed CSD is shifted to much higher charge states.74 
1.1.2 Native Mass Spectrometry 
Many studies have shown that the solvent composition encountered by proteins prior to nESI 
plays a significant role in the ultimate gas-phase structures and mass-to-charge ratio (m/z) 
observed from the resultant ions.65 For example, when proteins are exposed to denaturing buffers 
or solvents prior to nESI, the gas-phase ions created acquire a relatively large amount of ionic 
charge when compared to those ionized under native-like conditions.65 Typical solvent systems 
employed in such experiments include 50:50 water:methanol and water:acetonitrile mixtures, 
usually accompanied with a low percentage of acid. Such solution conditions disrupt the intra- 
and inter-molecular interactions within proteins and larger multiprotein complex systems.65 If 
these same experiments are performed using proteins prepared in buffered, aqueous solutions at 
pH 7, protein fold and quaternary structure can be maintained, to a certain extent, upon gas-phase 
ion formation by nESI.55,66 Ammonium acetate is typically added to maintain ionic strength and 
establish a weak buffer in such solutions, and is commonly utilized in such “native mass 
spectrometry” experiments.75-78 
Until the early 1990s, protein ESI-MS research was limited to denaturing conditions 
described above. Work done separately by Henison79 and Chait80 demonstrated that protein-
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ligand complexes could be observed by altering the electrospray conditions, specifically the 
pH.81 The following year, Baca and Kent performed the first MS experiment of an intact protein-
protein complex under similar solution conditions.75 Quickly, other research groups began 
studying intact multiprotein complexes of increasingly higher and higher mass and complexity 
for the study of protein-protein interactions.76-78,82 With the development of nESI, the field of 
native MS took another leap forward when Robison and co-workers demonstrated retention of 
protein-ligand complexes in the gas-phase, which were not observed under conventional ESI.83 
Work by Robinson and Heck has strived to push the field to study and characterize larger and 
more complex multiprotein complex systems. Complexes on the megadalton scale are now 
routinely studied,69,84,85 as well as methods to monitor protein dynamics86 and characterizing 
higher-order architecture.87 Recently, the compact, native-like architecture of such protein ions 
have been examined by ion mobility spectrometry (see below) and gas-phase spectroscopy 
measurements, and have revealed strong correlations in the higher-order structure between 
solvent-free proteins and those found in solution, while noting differences in their local 
structure.55,56,66,88,89 
1.2 Ion Mobility-Mass Spectrometry (IM-MS) 
Ion mobility (IM) separates ions based on their ability to traverse a chamber of inert neutrals 
under the influence of an electric field, resulting in longer transit times for ions larger in size or 
lower in charge and shorter transit times for those ions that are smaller in size or more highly 
charged.90 Since many of the physical principles that dictate ion transport under such conditions 
are well understood, ion drift times can often be easily converted to collision cross-­‐sections 
(CCS), precisely	   defined as a rotationally averaged ion-­‐neutral interaction potential.91,92 When 
combined with mass spectrometry (MS), the resulting multi-­‐dimensional IM-­‐MS technique can 
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provide a sensitive and efficient means of analyzing complex mixtures ranging from crude oil to 
cellular extracts.93-95 Recently, applications of the IM-­‐MS approach to challenges in structural 
biology and ligand screening have highlighted the ability of the technology to provide useful 
structure and stability information for protein samples difficult to analyze by other means.96-98 
Such experiments have concentrated on multiprotein targets, due to their central roles in many 
critical biological processes, and present a multi-­‐dimensional dataset from which gas-­‐phase data 
can be extracted in a manner that has been shown to correlate strongly with solution based 
measurements.19 
While there are several different commercially available platforms for performing ion 
mobility spectrometry (IMS), all fall into one of two groups: drift tube and differential devices. 
In drift tube devices, an analyte ion packet is introduced into a high-pressure drift cell under an 
electric field. Here all ions experience the same electric field and the time to traverse the drift 
cell is measured for all analyte ions (analogous to time-of-flight mass spectrometry; see section 
1.2.3). Differential devices behave similarly in that analyte ions are introduced into a high-
pressure cell and experience an electric field; however, they are introduced continuously and not 
all ions are detected under the same electric field conditions. In this instrument configurations 
analytes are separated by different electric field conditions (analogous to quadrupole mass 
spectrometry; see section 1.2.1). 
As mentioned above, only in the past decade or so has the utility of IMS been expanded 
to studying large multiprotein complex structures. Coupled together with MS, IM-MS separates 
ions in two orthogonal dimensions, providing complementary information on both analyte mass 
and size. Several commercial IM-MS instruments are available utilizing a variety of IMS and 
MS technologies. Here we use the commercially available Waters Synapt G2 HDMS, shown in 
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Figure 1-3, which is equipped with a nESI source, a high-m/z quadrupole mass filter, a traveling 
wave (T-wave) ion mobility drift cell, and a time-of-flight mass spectrometer. The inset of 
Figure 1-3 demonstrates how a packet of ions is introduced into the drift cell containing neutral 
gas molecules and is pushed through by the electric field, ions are separated within the cell based 
on their charge and size due to differences in the number of collisions with the neutral gas 
molecules.  The measured drift times can be converted to CCS values using celebrants with 
known CCS values following a standard protocol.91  
In addition to measuring ion CCS, protein structure transitions in the gas-phase can also 
be measured by IM-­‐MS using collision induced unfolding (CIU).96,99,100 A general approach for 
CIU measurements relies first upon ion selection within a quadrupole mass filter, and subsequent 
activation of the ion population of interest via collisions with Argon. For compact, low charge 
 
Figure 1-3. Schematic diagram of the commercially available Waters Synapt G2 HDMS 
nanoelectrospray-quadrupole-ion mobility-time-of-flight mass spectrometer. The instrument is 
equipped with an extended mass range quadrupole mass filter (32,000 Da) to allow for the analysis 
and selection of large analyte ions.  The inset depicts how a packet of ions is introduced into the 
traveling wave ion mobility drift cell and is pushed through a field of inert neutrals by a series of low 
voltage waves formed by a time-varying electric field. Ions are separated based on their charge and 
size.  The measured drift times can be converted to CCS values using calibrants of known CCS values. 
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state protein ions, this activation step induces protein unfolding.101 In the case of similarly 
compact multiprotein complexes, most models suggest that one subunit within the assembly 
primarily unfolds.57,65 In either case, multiple partially-­‐folded intermediate states are observed 
which are unique to the gas-phase, stable on a millisecond time scale prior to dissociation, and 
reflective of the pre-existing tertiary structure of the unfolding protein.57 In many cases, the 
appearance energy and CCS of these activated, intermediately unfolded conformers can be 
related back to protein-small molecule binding modes and stabilities using detailed comparisons 
and analysis.102,103 The following sections introduces the various elements of the Synapt G2 
instrument used throughout this thesis in the order in which they are encountered by ions 
transmitted from the nESI source (Figure 1-3).   
1.2.1 Quadrupole Mass Spectrometry 
Quadrupole mass spectrometers consist of four parallel rods that are evenly, radially distributed 
about the center-axis of the instrument.104,105 Opposing rods are electrically paired together, a 
combination of direct current (DC) and radio frequency (RF) voltages is applied to each rod-pair, 
where the DC voltage is the same for the two rod-pairs while the RF voltages oscillate at the 
same known frequency but are 180-degrees out of phase. At a specific combination of DC and 
RF potentials a quadrupolar field is created in which only a single m/z ion has a stable trajectory 
to reach the detector, all other ions have unstable trajectories and either collide with the 
quadrupole rods or are pumped away. Changing the quadrupolar field, by scanning over a range 
of DC and RF voltages, as a function of time enables the acquisition of a complete mass 
spectrum. A third mode of operation, in which the DC potential is zero (RF-only mode), allows 
the instrument to act as an ion guide, where a wide range of m/z ions are stable and can pass 
through the quadrupolar field. Since ions are continuously introduced into the quadrupole 
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analyzer, the technique is ideal for coupling with continuous ionization methods, such as nESI, 
and has been described in combination with both ion mobility106 and time-of-flight107,108 
analyzers to create powerful tandem MS instrument platforms for applications in complex 
mixture analysis,109 trace detection,110 and structural biology.23 
1.2.2 Traveling Wave (T-wave) Ion Mobility 
Many different IM-­‐MS instrument platforms have been described in the literature24, including 
the Synapt HDMS system.111-113 This particular platform uses a traveling wave (T-wave) ion 
guide to perform IM separation and was released as the first commercial IM-­‐MS platform in 
2006,111 followed by a second generation platform (Synapt G2 HDMS) in 2009 (Figure 1-
3).112,113 T-wave IM uses low-­‐voltage “waves” within a stacked-­‐ring ion guide pressurized with 
inert neutrals to separate ions according to their size-­‐to-­‐charge ratio. Wave Height ([WH]), Wave 
Velocity ([WV]), and pressure in the IM separator are all key parameters for optimized 
performance.113 Under high wave height and velocity conditions, with low pressure, T-wave 
instruments operate as ion guides, where there is no separation between differing ions due to the 
high energy barrier of the high wave height and few interactions with neutral gas molecule due to 
fast transit times at low pressure.111,114 By lowing the wave height and velocity, while increasing 
pressure within the T-wave, ions of differing size-to-charge are separated due to the higher 
number of collision with neutral gas molecules due to slow transit times at higher pressure, and 
the possibility of rollover between consecutive electric field waves due to the decreased energy 
barrier associated with lower wave height.111,114 The resolution of IMS data is characterized by 
several different factors including diffusion, space charge, initial pulse width, reaction chemistry, 
and conformational changes.113 It is commonly assumed within the field that the total resolution 
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can be approximated by the effects due to diffusion alone.113,115 Under such diffusion-limited 
conditions in T-wave instruments, resolution (RTW) can be defined by: 
 𝑅!" = !! !!" WH WL !"WV !" ln ! ! ! (1.3) 
where z is the ion charge, e is the electron charge, [WL] is the wave length, K is the ion mobility, 
E is the field strength, k is the Boltzmann constant, and T is the temperature in the T-wave ion 
guide.113,115 From this equation, it is clear that resolution can be greatly influenced by multiple 
instrument parameters, making this methodology more advantageous over the traditional linear 
drift tube, which can only be influenced by a single instrumental variable, the electric field.113 
However, the T-wave resolution is limited by the capabilities of the instrument components 
(maximum/minimum achievable parameters), whereas the linear drift tube is theoretically 
limitless by increasing the length of the drift tube.48 
The Synapt G2 was modified from the first generation instrument to enhance 
performance and resolution. Key differences between the first and second generation Synapt 
instruments include: 1) a longer IM separation region, 2) an ion guide pressurized with He gas 
between the trap and IM separation regions tuned to reduce activation upon ion injection, 3) 
increased pumping conductance in the ion trap and transfer regions enabling higher operating IM 
pressures (up to 4mTorr of N2), and 4) differential pairing of electrodes within the stacked ring 
ion guide that enables larger applied fields for IM separations (up to 90% of the field applied at 
the electrode surface). For all T-wave IM instruments, calibration with ions having known CCS 
is necessary to determine CCS values for unknown analytes. 
1.2.3 Time-of-Flight (ToF) Mass Spectrometry 
A basic time-of-flight (ToF) mass spectrometer is composed of three components: 1) an ion 
pusher, 2) a flight tube, and 3) a detector. In the pusher, ions are pulse injected into the flight 
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tube as a packet such that ions of equivalent charge in the packet are given equivalent kinetic 
energy, where ions of higher charge have higher kinetic energy. In the flight tube, ions separate 
due to differences in velocities since kinetic energy is directly proportional to both the mass and 
the velocity squared. Therefore, more massive, lower charged ions will traverse the flight tube at 
a slower velocity than less massive, higher charged ions, which have faster velocities.  All ions 
must traverse the same distance in the flight tube to reach the detector. Since the ions have 
different velocities, the time each ion takes to reach the detector is recorded and is directly 
related to the m/z by: 
 𝑡 = !!! !!  (1.4) 
where d is the fixed distance the ion travels through the drift tube and U is the electric potential 
applied in the pusher to give all like charged ions equivalent kinetic energy. 
 The physics of ion motion in the flight tube is well understood, where decreased peak 
resolution in the flight tube can be attributed to diffusion. The region that effects the peak 
resolution the most in the pusher. In an idealized instrument, ions in the pusher would all have 
the same initial position, be stationary, and accelerate to the same kinetic energy in a single 
acceleration event before entering the flight tube at the same time. In a single acceleration, due to 
differences in initial position within the pusher region, ions of the same m/z will accelerate 
differently. Ions in the pusher initially positioned closer to the flight tube entrance will be 
accelerated for a shorter period of time before entering the field free flight tube, and will 
therefore have lower kinetic energies than those positioned further from the drift tube, assuming 
the ions have equivalent trajectories before acceleration. Additionally, ions of the same m/z and 
are at the same position within the pusher, but have different trajectories before acceleration, will 
leave the pusher at the same time, however, they will have different velocities. To account for 
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these differences in spatial position and trajectories, a duel-phase acceleration is known as 
delayed pulse excitation is performed.116 Under this protocol, ions are allowed to separate in a 
field-free region before acceleration to allow of the same m/z but with different trajectories to 
separate in space. When the acceleration voltage is applied after a fixed delay time, the ions with 
higher initial velocities will be positioned closer to the flight tube entrance while ions with lower 
initial velocities will be positioned farther away. The ions closer to the entrance will accelerate 
for a shorter period of time and ultimately have a lower velocity in the flight tube that the ions 
which were farther from the entrance and experienced the acceleration voltage for a longer 
period. The delay time and the acceleration voltage can be tuned such that ions of a particular 
m/z will reach the detector at the same time. This process of space focusing is optimized for a 
single m/z, but also improves resolution for similar ions. To velocity focus a broader range of 
different m/z ions additional methods are implemented. 
 Most commercially available ToF instruments are equipped with one or more of a fourth 
element, a reflectron. When ions are ejected from the pusher into the flight tube, two ions with 
the same m/z theoretically have the same kinetic energy, and therefore the same velocity; due to 
differences in starting trajectories within the pusher, this is not the case. The purpose of the 
reflectron is to compensate for the different velocities of equivalent m/z ions.117 To achieve this, 
the reflectron acts as an ion mirror, where a series of equally spaced ring or grid electrodes 
creates an electric field to redirect the ions, in a fashion similar to light on a mirror, toward the 
detector or a successive reflectron. Ions of greater velocity will penetrate the electric field more 
deeply and take a longer time to reach the detector, while ions with lower velocity will penetrate 
less deeply and more quickly reach the detector. Properly configured, the difference in flight 
distance caused by the reflectron will normalize equal m/z ions of different velocities to the same 
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flight time, and therefore produce higher resolution mass spectra.117 As a consequence of the 
reflectron, ions travel a greater distance, allowing ions of similar m/z to become more temporally 
separated, and therefore, improve spectral resolution.117 
1.3 Protein Complex Subunit Analysis in Mass Spectrometry 
In order to construct a model of a multiprotein complex it is essential to accurately measure the 
size of not just the intact complex, but also the individual subunits and subcomplexes that make 
up the intact system.38,118,119 Such measurements define the detailed protein-protein connectivity 
and distances within the assembly, and act as constraints for computational simulations of model 
topology.38,50,118,120 Such information is typically acquired in two generalized modes: solution 
disruption and gas-phase dissociation. The first strategy is characterized by altering solution 
conditions such that inter-molecular interactions are disrupted while intra-molecular interactions 
are preserved.97 The latter strategy is characterized by introducing energy to the intact complex 
ions within the gas phase.121 
1.3.1 Solution Disruption Strategies 
Through the alteration of solution composition, protein-protein interfaces can be disrupted 
differentially based on their chemical compositions, stabilities, and structures.97 For example, 
hydrophobic interactions are disrupted by the addition of organic solvents87,118,122,123 while salt 
bridges are disrupted by increasing the ionic strength of the buffer.123,124 While these approaches 
are currently our most effective means for generating native-like protein sub-complexes and 
subunits for IM-MS measurements,97 care must be taken to retain the folds of individual proteins 
following disruption.50 Indeed, the retention of protein tertiary and secondary structure following 
protein-complex disruption is not always possible due to the tight, domain-swapped architecture 
of some protein interfaces.125 In addition, solution-phase protein disruption is both slow and 
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relatively poorly understood on a mechanistic level when compared with gas-phase 
methodologies (see below, Section 1.3.2),19 although recent efforts have been made to perform 
rapid, comprehensive solution-phase disruption experiments for IM-MS.50 As such, there is a 
strong motivation to develop gas-phase dissociation experiments that enable the generation of 
compact, “native-like” product ions.  
1.3.2 Gas-Phase Complex Dissociation 
An alternative approach to generating subunits and subcomplexes of multiprotein complexes is 
through dissociation in the gas phase.  Currently, there are several different commercially 
available dissociation techniques used within the field of structural biology: collision induced 
dissociation (CID), surface induced dissociation (SID), and electron transfer dissociation 
(ETD)/electron capture dissociation (ECD). Of the available techniques, the latter two add 
energy to precursor ions on the ps or fs timescales, which means that a single electron capture or 
surface collision event induces protein complex dissociation. CID, on the other hand, is a slower 
technique in which dissociation is induced over a series of energy transfer events between the 
background gas (typically Argon) and the precursor ion. These generalized differences between 
the technologies give rise to both different product ions and information content. Figure 1-4 
demonstrates the dissociation pathways available across these different technologies as described 
currently in the literature.82,126-137 
 CID occurs when an ion is accelerated in an electric field and allowed to collide with 
neutral gas molecules at elevated kinetic energies.138 The ion experiences multiple collisions, 
which convert its starting kinetic energy to rotational/vibrational internal energy on the 
microsecond timescale.138 The collisional event that takes place during CID can be viewed in one 
of two frames of reference: the laboratory frame of reference and the center-of-mass frame of 
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reference.139 Under the lab frame of reference, the neutral gas-molecule is considered stationary, 
and therefore the kinetic energy of the collision can be simplified as the kinetic energy of the 
analyte ion, which is expressed as the product of the analyte charge state and the acceleration 
voltage. The CID dissociation pathway for protein complexes most commonly observed for 
native MS experiments is shown in the center of the blue region of Figure 1-4. Under these 
conditions, dissociation proceeds via an asymmetric charge partitioning pathway, where a single 
subunit from the complex dissociates from the remaining subcomplex while carrying a majority 
of the parent ions charge.82,126-129 This phenomenon is observed across a wide range of proteins, 
 
Figure 1-4. Dissociation pathways for collision induced dissociation (CID, blue), surface induced 
dissociation (SID, pink), and electron transfer dissociation/electron capture dissociation (ETD/ECD, 
yellow). The three different CID pathways are charge dependent, where the central pathway is most 
dominant for traditional charge states observed in native mass spectrometry and is characterized by the 
unfolding and dissociation of a single subunit, with that subunit carrying the majority of the charge 
from the precursor ion. When supercharged, the right pathway is observed, converting the unfolded 
subunit into peptide ions. The left pathway demonstrates dissociation from reduced charge states, 
where dissociation of a compact subunit is observed. The fast, high-energy collisions used in SID 
allow for the elimination of protein unfolding, producing compact, intact subcomplex ions. ETD/ECD 
proceeds to generate an unstable radical ion which undergoes backbone dissociation of a single 
subunit to generate peptide ions. 
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from the cytochrome C dimer where two distinct monomer CSDs are observed128, to the 
tetradecamer GroEL, which dissociates into monomer and tridecamer where the monomer caries 
up to 58.5% of the parent ions initial charge.140 With the advent of IM-MS instruments capable 
of studying multiprotein complex ions in the gas-phase, we now know that subunit unfolding 
within a complex occurs, while the overall complex stoichiometry is maintained.57 During this 
unfolding, charge likely migrates over the surface of the complex to maintain a uniform surface 
charge density over newly-formed unfolded gas-phase structures. Once sufficient unfolding 
within a single subunit has taken place, it dissociates and carries away a disproportionate amount 
of charge relative to its mass.57 Since subunit unfolding plays a major role in this mechanism, the 
dissociation process is now often described as a symmetric charge partitioning process relative to 
the surface area available to the complex in the transition state.141 
 The asymmetric charge partitioning mechanism discussed above is not the only observed 
CID dissociation pathway for protein complex ions.  Other pathways have been observed, often 
driven by an altered precursor ion charge state. For example, under supercharging, or charge 
amplification, conditions (right pathway of blue region in Figure 1-4), ions with amplified charge 
are accelerated to larger kinetic energies and thus undergo enhanced vibrational/rotational 
heating during CID.39 Thus, primary monomeric product ions, likely produced by a mechanism 
similar to the asymmetric charge partitioning model described above, undergo further 
dissociation to generate peptide ions, which can be used to perform top-down type sequence 
analysis.131 Alternatively, if the charge on precursor ions are reduced (left pathway of blue region 
in Figure 1-4), decreased Coulombic repulsion on the surface of the protein limits the extent of 
subunit unfolding. Although the CID of charge reduced protein complex ions has been shown to 
abrogate all subunit unfolding during collisional activation and lead to compact product ions, 
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general trends for this phenomenon are still unknown.130 In addition, exceptions to the general 
trends presented in Figure 1-4 have been described in the literature,130,142-144 highlighting the 
need for a more complete understanding of protein complex CID.  Complete control over the 
protein complex CID mechanism, however, will undoubtedly lead to transformative structural 
biology methods that enable the rapid construction of multiprotein models.19,38,118 
 Relatively recently, protein complex dissociation in the gas-phase through SID and 
ETD/ECD has been demonstrated, and each of these methodologies offer orthogonal information 
content to the CID experiments described above. SID, like CID, occurs when the analyte is 
accelerated using an electric field to create an activating collision.  However, in SID the collision 
event is a single collision with a stationary surface. As such, the timescale of ion activation is 
substantially shorter, significantly altering the resulting dissociation pathway and product ion 
populations produced. As depicted in the pink region of Figure 1-4 (lower left side), SID 
produces compact subcomplexes capable of producing useful topology information when 
coupled with IM-MS.132-135 
ETD/ECD based product ions are formed in a rapid manor where excess energy comes 
from a captured, low-energy electron resulting in an electronic excitation event that produces 
product ion on the fs timescase, unlike CID which is coupled to rotational/vibrational activation 
on a much longer ms timescale.145 As a result, the observed dissociation products from ETD and 
ECD are very different from slower methods. ETD and ECD both proceed after the generation of 
gas-phase radical ions generated through the reaction of the analyte with either an anion (in 
ETD)146,147 or directly with an electron (in ECD), resulting in an excited radical.145,148 For protein 
complexes, this excited state induces backbone dissociation of a single subunit to generate 
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peptide ions (as presented in the yellow, lower right region of Figure 1-4), which can be used in 
top-down sequencing efforts.136,137 
1.4 Charge Manipulation Techniques 
As mentioned above, and shown in Figure 1-4, charge manipulation has been observed to 
dramatically alter the CID pathway of multiprotein complex ions.130,131 For purposes of modeling 
protein complex topologies from IM-MS datasets, charge reduction represents a pathway to 
produce useful protein complex substructure information by enabling accurate size 
measurements of protein building blocks. However, in order to engage such alternative 
pathways, charge states must be altered from their native CSDs. To do this, two broad classes of 
approaches have been previously taken: use of solution additives that act to alter the ESI process 
in order to shift CSDs149-160 or instruction of gas-phase reagents to react with protein ions in 
order to shift CSDs either during or post ionization.161-176 
1.4.1 Solution Based Methods 
Both modification to aqueous buffer compounds 134,135,153,160,177,178 and the addition of specific 
bases155,179 have been demonstrated as effective solution-phase approaches for reducing the 
resultant charge state of protein ions produced by nESI.  Most alternative buffer options 
currently known act to shift protein charge states to lower values than those commonly 
encountered when using standard aqueous ammonium acetate buffer.153,155 The buffers typically 
used are most often derived from ammonium acetate or ammonium bicarbonate buffers.152-154 
The most commonly used of these are triethylammonium acetate (TEAA) or triethylammonium 
bicarbonate (TEAB).134,135,160,177,178 On the other hand, when solution additives are used to 
perform charge reduction they are usually strong gas-phase bases, and are selected to operate 
under the same principles as the alternative buffers described above.155,179 Both protocols are 
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thought to operate under a shared mechanism that acts to reduce the final charge state observed 
for nESI produced ions.155 As show in Figure 1-5a, during the final stages of ionization, charge 
reducing species are hydrogen-bonded to protons at basic sites across the surface of the analyte 
protein.  As desolvation continues, the protons are stripped from the surface of the protein as the 
basic species are ejected as charged species; this step is driven by the proton affinity of the basic 
site on the protein and the gas-phase bacisity of the charge reducing species. 
Unlike charge reduction, which is likely driven by a charge stripping mechanism that 
takes place during the later stages of nESI ionization, supercharging in nESI can also proceed by 
altering the physical properties of the droplet in order to influence the ionization mechanism.158 
Typically, this is done by adding agents that increase the surface tension of the solvent in order 
 
Figure 1-5. Charge reduction pathways for (a) solution additive and (b) gas-phase methodologies. In 
solution additive charge reduction, during the final stages of ionization charge reduction agents (here 
represented as DBU) are hydrogen-bonded to protons at basic sites across the surface of the protein.  
As desolvation continues, the protons are stripped from the surface of the protein as the basic species 
are ejected from the surface as ions. In gas-phase charge reduction, charge reducing agents (Y) can 
exist as both neutral or ionic species, and bond with protons on the surface of the droplet. Similar to 
solution charge reduction methods, surface charges are stripped based on proton affinity in ion-neutral 
reactions or are stripped/neutralized due to ion pairing or in ion-ion reactions. 
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to increase their charge density at the Rayleigh limit. An array of such supercharging reagents 
are available, with two of the most common being sulfolane and m-nitrobenzyl alcohol (m-
NBA).150,151,156,157 However, the mechanistic details of the charge amplification process are still 
an active area of research,157,160 and there is strong evidence that such supercharging processes 
disrupt the structure of the proteins, making the current methods difficult to implement with IM-
MS for analyzing multiprotein complex structures.159,160,180 
1.4.2 Gas-Phase Methods 
Like solution based charge manipulation methods, there are two different gas-phase approaches: 
ion-neutral reactions and ion-ion reactions. In such methods analyte ions react in the gas-phase 
with either counter ions or neutral reagents in an effort to either neutralize or strip protons from 
the protein, or to add protons when supercharging ions.163,175,181 Additionally, there are two 
different protocols for introducing such gas-phase reactants to protein ions: charge manipulation 
can occur continuously in regions within or near the ESI source (such as the work done by Smith 
and co-workers),164-168 or ion traps can be utilized to store analyte ions for subsequent reactions 
with neutrals or ionized species (such as the work done by McLuckey and co-
workers).169,170,172,174 
 The earliest examples of gas-phase charge reduction used ion traps to store analyte ions 
and react them with a basic background gas (e.g. diethylamine) at pressures that ensured multiple 
collisions by reducing the mean free path of ions stored within the trap. Varying the trap times of 
the analyte affected the extent of charge reduction.161 Similarly, ion-ion reactions can be 
performed in ion traps. For such experiments, analyte ions are typically stored, but rather the 
being exposed to relatively large numbers of neutrals reagents, ions of opposite polarity are 
generated from a secondary ion source and introduced into the trap using customized 
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waveforms.174 The two ions are then allowed to react in the trap for controlled periods of time 
before mass analysis.169-174 While there is evidence that compact native-like gas-phase 
conformations are retained during this process provided trapping times are short,182 it is clear that 
increased trapping times are required to sufficiently reduce higher charge state ions, and with 
high mass analytes typically possessed of higher charge states, such extended trapping times are 
a concern for applications in structural biology. 
 Continuous methods for charge reduction are advantageous since they can generate 
charge reduced ions at a rapid rate due to the increased collision frequencies available between 
analyte and reagent, mitigating many of the potential issues that arise from extended trapping 
periods. However, as trapping times proved to be an important variable for controlling charge 
states in the experiments described above, gas-flow rates for the charge reducing species are 
equally important for controlling charge reduction in the nESI source.163,168,183 Early work used a 
capillary mixing tee to combine analyte ions with either counter ions or neutral reagents.162,163 In 
these experiments, charge reduction occurs after the generation of gas-phase analyte ions.162,163 
Alternative methods have been developed subsequently, where charge reduction occurs in the 
ion source prior to complete desolvation of the analyte nESI droplets.164-168 Such early methods 
where dominated by ion-ion reactions where reagent ions are generated through either corona 
discharge166-168 or from radioactive targets.164,165,168 Recently, in source ion-neutral approaches 
have become more prevalent for reducing charge on nESI droplets.184-186 Figure 1-5b shows the 
current model for such charge reduction reactions within the source region of the instrument. 
Here, charge reducing agents, neutrals or ions, interact with protons on the surface of the droplet. 
Similar to solution-phase charge reduction methods, surface charges are stripped based on proton 
affinity, or are neutralized through bound counter ion charge.  
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 Recently, an ion-neutral supercharging approach has been developed for in source charge 
amplification of protein ions produced by nESI.175,176 The method uses sheath gas seeded with 
acidic species to initiate proton transfer reactions that lead to highly charged protein ions 
independent of their starting solution condition. As there is strong evidence that links solution-
phase supercharging reagents to protein unfolding, leading to altered gas-phase protein 
structures,160 a gas-phase methodology potentially provides key advantages to retaining compact 
protein states by generating amplified protein charge states in the later stages of their formation. 
There is, however, evidence to support that even gas-phase methods for protein ion 
supercharging results in altered protein conformational states in the gas-phase,175 necessitating 
further research and method development in order to apply such methods to challenging 
structural biology targets. 
1.5 Modeling Protein Complex Structures with IM-MS Datasets 
The ultimate goal for IM-MS measurements in the context of structural biology is to generate 
three-dimensional models of multiprotein complexes, constrained by connectivity and size 
measurements acquired in the gas phase. The model generation process typically begins by 
constructing a starting state from available protein composition information, and inputting 
available constraints from IM-MS measurements to begin the refinement process. If high 
resolution structures are available, Monte Carlo simulations can be performed that simulate the 
IM experiment and estimate the CCS of protein conformers for direct comparison with 
experimental data.187 To generate accurate depictions of small gas-phase protein structures and 
peptides, simulated annealing must be carried out to relax X-ray and NMR structures to their 
lowest-energy gas-phase conformer for comparison with IM data.188 Multiple algorithims are 
available for comparing experimental CCS data with CCS estimates derived from model 
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structures.189-194 These include various projection approximations,189,190 the exact hard-sphere 
scattering method,191 the trajectory method,192 the projection superposition approximation,193 and 
detailed calculations of polyatomic momentum transfer.194 To provide accurate models, all 
methods other than projection approximations require detailed simulations of gas-phase 
structure, and are thus not typically suitable for work with large multiprotein complexes,19 
relegating most IM-MS models of such systems to coarse-grained representations.19,38,118 Coarse-
grained structures of multiprotein complexes can be generated directly from IM-MS datasets by 
measuring CCS values for monomers, subcomplexes and intact assemblies, and using all of this 
information to constrain a subunit-level model of the assembly under investigation.38,120 
Typically, protein-protein distances and connectivities are input into a Monte Carlo-guided 
random walk that searches protein topology space for those solutions that best satisfy the IM-MS 
data.120 The output of such simulations typically take the form of clusters of models, with the 
confidence interval of the final model largely defined by the number of experimental constraints 
and the number of interacting proteins within the assembly studied.     
1.5.1 Molecular Dynamics: Simulated Annealing 
When all-atom structures are available for subunits of multiprotein complexes, simulated 
annealing can be used to probe the structural landscape of the protein in the gas phase to generate 
models of its low energy structures in vacuo.188,195 In simulated annealing, all-atom structures are 
subjected to a series of gradual temperature ramps, where raising the temperature increases the 
energy of the system in order to disorder the structure.196 As the temperature is decreased the 
system refolds to form alternative structures. Each temperature increase is followed by a 
decrease in an effort to move the protein structure from local minima on the potential energy 
surface, eventually funneling toward its lowest energy configuration.195 All of the structure 
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produced can be evaluated in comparison to CCS measurements as described above. Models 
found in good agreement are identified as candidate gas-phase structures and can be used to 
guide downstream experiments.120 Due to the many challenges associated with finding low 
energy structures of large protein chains and multiprotein complexes, such simulated annealing 
approaches are typically limited to peptides and proteins less than 12 kDa.  For larger systems, 
the details of gas-phase structure are ignored to produce coarse-grained models through the 
Monte Carlo simulations discussed below.38 
1.5.2 Monte Carlo Simulations 
In order to generate coarse-grain structures of multiprotein complex systems, subunits are 
typically represented as spheres, where the size of the sphere correlates to the measured CCS 
from IM-MS measurements. These spheres are used to build subcomplexes, and ultimately the 
full multiprotein complex, by searching the conformational space between two subunits, a 
subunit and subcomplex, or two subcomplexes by altering protein distances, angles, and 
positions based on experimental CCS constraints. The best subcomplex model is selected and 
treated as constant for searching the conformational space of the next measured species.118 Such 
coarse-grain models can be integrated with X-ray structures of subunits, homology models, or 
structures generated from simulated annealing to build all-atom, or partially refined, models.38 
1.6 Summary 
Classical tools for determining the high-resolution structures of multiprotein complexes are 
limited in terms of their ability to deal with samples comprised of mixtures, where the target 
protein is present at low levels, or possesses flexible or polydisperse regions. IM-MS offers the 
ability to overcome many of these challenges, but the generation of sufficient data to provide 
constraints for the final models can be a challenge. For example, gas-phase measurements of 
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intact complexes, subunits, and subcomplexes are all needed to generate complete structures, and 
must correlate well with native, biologically relevant structures found in solution in order to 
provide relevant models. While strong correlations have been discovered that link solution and 
gas-phase protein structure, IM-MS is currently bottlenecked in its ability to generate and study 
native-like subunits and subcomplexes from intact assemblies. 
CID of protein complexes provides a promising experimental route to the information 
needed to build models of multiprotein complexes using IM-MS, but a more detailed 
understanding of the CID mechanism at work for protein complex ion precursors is necessary in 
order to effectively use such data.  Evidence of CID from low charge state parent ions suggests 
that compact, native-like structures can be retained in the gas phase; however, this dissociation 
pathway is not completely understood. In order to study this pathway, charge reduction must be 
able to effectively generate reduced charge states while simultaneously retaining native-like 
conformations in the gas-phase. Such charge reduction can be performed in solution or in the 
gas-phase. Solution based methods for charge reduction, while proven effective, show evidence 
of altered protein structures due to extended interactions with charge reducing agents. Gas-phase 
methods for charge reduction are advantageous in that analyte interactions with charge reducing 
agents are shorter and less likely to perturb native-like structures. However, few detailed studies 
have critically evaluated the information content of such ions for structural biology. 
In Chapter 2, a newly designed source for performing gas-phase ion-neutral charge 
reduction is tested and evaluated against a solution additive approach in order to develop a 
method for producing low charge state gas-phase ions with retained native-like conformations. 
(Published, Bornschein, R.E.; Hyung, S.-J.; Ruotolo, B.T. Ion Mobility-Mass Spectrometry 
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Reveals Conformational Changes in Charge Reduced Multiprotein Complexes, Journal of 
the American Society for Mass Spectrometry 2011, 22, 1690-1698.) 
In Chapter 3, two homotetramers, avidin (64 kDa) and aldolase (157 kDa), are 
exhaustively screened for CID and CIU thresholds across all traditional, native MS charge states 
down to charge states that are ~37% charge reduced relative to the highest observed charge state. 
Two distinct dissociation pathways are observed at low charge states, both of which produce 
product ions from compact tetramer conformations. Modeling reveals previously unkown, large-
scale structural rearrangements that occur on the sub-millisecond timescale. 
In Chapter 4, a range of multiprotein complexes with varying mass, complex topology, 
and stoichiometry are evaluated using gas-phase ion-ion charge reduction to identify charge 
states where CID is observed prior to CIU.  These data are then used to predict candidate charge 
states to select as CID precursors broadly, which can be used to extract compact subunit 
information for multiprotein complex topology construction efforts. 
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Chapter 2. Ion Mobility-Mass Spectrometry Reveals 
Conformational Changes in Charge Reduced Multiprotein 
Complexes 
Bornschein RE, Hyung S-J, Ruotolo BT, Ion Mobility-Mass Spectrometry Reveals 
Conformational Changes in Charge Reduced Multiprotein Complexes, Journal of the American 
Society for Mass Spectrometry (2011) 22: 1690-1698. 
 
2.1 Introduction 
Over the last twenty years, the interconnected nature of life processes has been revealed through 
the development of analytical approaches that are able to capture and characterize the complexity 
of interacting proteins and other biomolecules. Because virtually all cellular processes are 
interconnected, protein assemblies consisting of multiple components have critical significance 
in health and medicine. Mass spectrometry (MS) has been a key tool in assessing such complex 
biological systems.1,2 These experiments have been conducted using both “bottom-up” methods, 
where interacting partners are detected either by defining the composition of fractions derived 
from affinity capture or by chemical crosslinking,3,4 and “top-down” approaches, where the 
interaction network is observed intact by MS.5,6 Both types of datasets have been instrumental in 
defining contact diagrams for protein interaction networks, and can often provide limited 
information on the three-dimensional structure of such assemblies.7,8 
The incorporation of ion mobility (IM) separation into such MS experiments is an 
important emerging approach for the structural characterization of biomolecules and their higher-
order complexes.9-11 Following on from early results indicating that the topology and quaternary 
organization of multiprotein complexes can be assessed and related to structures determined 
 39 
 
using X-ray crystallography and nuclear magnetic resonance spectroscopy,12,13 the applications 
of IM-MS to protein assemblies have increased dramatically. Recent examples include studies 
aimed at assessing binding events within protein cavities,14 refining protein interaction 
networks,15,16 characterizing multiprotein complexes bound to small molecules,17 and assessing 
the relative stability of membrane protein complexes.18 In all of these reports, IM provided a 
critical structural assessment of a multiprotein complex system found difficult or impossible to 
characterize using other structural biology technologies. 
In multiple studies, the influence of protein complex ion charge state is often highlighted 
as a key factor in altering the information content of IM-MS and tandem MS measurements.13,14  
For example, the collision induced dissociation (CID) process for natively-charged multiprotein 
complexes produced by nano-electrospray ionization (nESI) often results in an effective charge 
reduction step, where the stripped protein complexes that have lost a monomeric unit also lose a 
large portion of the charge originally carried by precursor ions.5,19 This effect has been used to 
great advantage to characterize polydisperse protein complexes for which the primary ion mass 
spectrum is difficult to interpret due to spectral overlap.20 Further, several datasets have 
highlighted the influence of precursor ion charge state on both the structure and type of product 
ions produced from multiprotein complex CID. Recent data have highlighted the ability of ion 
charge state to alter the apparent mechanism of dissociation, where precursor ions of lower 
charge tend to eject compact (rather than the typically unfolded) monomers.21 Additional 
datasets have indicated similar effects for charge amplified protein complexes in specialized 
cases.22,23 In datasets where extremely low or high charge states are achieved through altering 
either solvent composition or nESI emitter position, covalent bonds rather than non-covalent 
protein-protein interactions can be broken to produce sequence informative fragment ions.21,22 
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A further set of charge-related effects observed for multiprotein complex ions center on 
datasets that demonstrate the apparent reliance of gas-phase structure upon ion charge state.  In 
most cases, protein ions display a distribution of charge states when produced through nESI, and 
IM and MS measurements indicate that ions having the lowest ionic charge are  the most ‘native-
like’,11,13,24 in that ions of low charge state are, in general, resemble  X-ray and nuclear magnetic 
resonance (NMR) datasets the best in terms of rotationally-averaged sizes 25-27 and are the most 
useful data points when constraining topological models of multiprotein complexes from IM-MS 
data.16 For example, in early experiments involving tryptophan-RNA binding attenuation protein 
(TRAP) 11-mer ions, higher charge states were observed to be more compact relative to ions 
having lower charge.13 The charge state dependent nature of protein complex structure has also 
been observed in other datasets, including a large database of high-precision collision cross-
section measurements, in which both increases and decreases in ion size as a function of charge 
state are observed28.  Although all of these reports end with similar conclusions regarding the 
influence of charge on gas-phase protein structure, the mechanistic details that lead to this 
apparent charge-state dependant behavior have yet to be completely elucidated.  
There are multiple methods and protocols available for manipulating the charge state of 
ions produced by nESI.29-39 In general, charge manipulation is achieved using three strategies: 
solution additives, ion-neutral chemistries, and ion-ion chemistries. Methods that utilize solution 
additives are among the simplest approaches to implement experimentally,31 but have distinct 
disadvantages for the analysis of multiprotein complexes where the stability of the assembly may 
be altered significantly through only small changes in solution composition, pH, or ionic 
strength.40 Ion-ion chemistries allow for fine control and high efficiency in manipulating the 
charge states of biomolecules, but require either modified ion sources or specialized ion trap 
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approaches for successful charge reduction or amplification.36,39 Approaches centering upon ion-
neutral chemistries are inherently less efficient that those described above,30 but combine some 
of the simplified aspects of solution additive approaches with the fine control of ion-ion 
approaches for the generation of charge-modulated biomolecular ions. Critically, there is little 
data currently that describes the relative influence of these different charge modulation strategies 
on the gas-phase structures of biomolecular ions, with the majority of data focused on 
monomeric proteins.29,41-46 Multiprotein complexes have been charge-modulated using primarily 
solution additive-type strategies,31 but the influences of such approaches on the quaternary 
structure of multiprotein complexes in the absence of bulk solvent is poorly understood.  
In this report, we compare charge reduction methods based on solution-additives to that 
based on gas-phase ion-neutral reaction chemistry by assessing and comparing the structures of 
the ions generated in terms of their collision cross-sections as a function of charge state. We find 
that while both approaches achieve similar amounts of charge reduction, ranging from 2.1-27% 
efficiency, the solution based-additive approach studied here requires significant levels of 
collisional activation in order to shed positive ions and generate charge reduced protein complex 
ions. Therefore, the ions produced by the solution-additive based method produce larger ions 
having undergone conformational rearrangements and unfolding.47 Conversely, the gas-phase 
ion-neutral approach universally produces compact, native-like ions. Critically, charge reduction 
carried out by ion-neutral chemistry in the gas-phase can impart similar charge reduction 
effectiveness when compared to analogous solution-phase approaches, without the need to 
introduce solution additives that may act to disrupt the oligomeric state or structure of ions prior 
to nESI analysis. Thus, we demonstrate that charging on multiprotein complexes by ESI can be 
modulated by the gas-phase ion-neutral chemistry methods described herein, and can be further 
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applied to CID to improve the utility of IM-MS as a tool for characterizing structure of 
biomolecules. 
2.2 Experimental 
The protein complexes studied here, avidin (chicken egg white), alcohol dehydrogenase (yeast, 
ADH),and pyruvate kinase (rabbit muscle, PK), were purchased from Sigma-Aldrich (St. Louis, 
MO) as well as ammonium acetate and the charge reducing bases triethylamine (TEA), 1,5-
diazabicyclo[4.3.0]non-5-ene (DBN), and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). Protein 
stock samples prepared to 100 or 50 µM in 100 mM ammonium acetate (pH 6.9) were buffer 
exchanged into 100 mM ammonium acetate using Micro Bio-Spin 6 columns (Bio-Rad, 
Hercules, CA) and diluted to a final concentration of 10 µM with 100mM ammonium acetate. 
Protein samples prepared with solution additives contained charge reducing agents at 
concentrations of 5-20 mM. For the study of gas-phase ion-neutral reactions, aqueous solutions 
of the charge reducing agents TEA, DBN, and DBU were prepared to 1.4 M, 1.7 M and 0.7-2.0 
M concentrations, respectively.  Bases were chosen based on their common use in previous 
experiments involving multiprotein complexes both in our lab and others.31 
Ion mobility-mass spectrometry experiments were performed on a quadrapole-ion 
mobility-time-of-flight mass spectrometer (Q-IM-ToF MS) purchased from Waters (Synapt G2 
HDMS, Manchester, UK).  While earlier versions of the Synapt instrument platform utilizing a 
nano-electrospray ionization (nESI) source were also fitted with a reference emitter that included 
a nebulizing sheath flow, the reference sprayer provided by the manufacturer for the nESI source 
on the Synapt G2 does not.  Figure 2-1 shows a schematic diagram of the modified nESI ion 
source, where the nESI reference sprayer is replaced with a simple nebulizer which acts to 
introduce neutral base molecules into the source near the sampling cone, perpendicular to the 
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analyte spray, allowing ion-neutral chemistry to occur before protein ions enter the sampling 
orifice. The device was designed to introduce base into the source through a stainless steel 
capillary; the capillary passes through a hollow chamber within the sprayer, which directs to 
sheath gas flow. The sprayer tip then focuses the sheath gas to pass directly over the capillary tip 
in order to nebulize the base molecules. The sheath gas used is nitrogen and base flow rates 
range from 10-25 mL/hr with the gas pressure optimized for continuous nebulized droplet 
formation ranging from 20-35 psi. A typical nebulizer flow rate used in these studies is 10 
	  
Figure 2-1.   A schematic diagram of the modified nanoelectrospray ion source for the Synapt G2 
instrument used in these studies. Nebulized base molecules are introduced into the source 
perpendicular to the analyte spray. Base solution flows through a stainless steel capillary, which is 
enclosed in a hollow chamber within the sprayer. Sheath gas flows through the hollow chamber and 
exits out the sprayer tip.  The tip is designed to force sheath gas over the end of the capillary, causing 
the base to nebulize for interaction with electrosprayed protein complex ions. 
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mL/hr, with a gas pressure of 20 psi. 
To generate protein complex ions, an aliquot of sample (~5 µL) was sprayed from the 
Nano-Lock Spray with the capillary voltage ranging from 1.8-2.0 kV, with the source operating 
in positive mode and the sample cone operated at 20 V. The trap travelling-wave ion guide was 
operated with an argon gas pressure of 3.3×10-2 mbar and a 50 V trap bias (as much as 150 V 
was used in solution phase charge reduction experiments). The travelling-wave ion mobility cell 
was operated with a nitrogen gas pressure of 3.5 mbar and employed a series of DC voltage 
waves (wave heights: 30-35 V, wave velocities: 500-600 m/s) to generate ion mobility 
separations. The ToF-MS was operated over an m/z range of 800-15000 with a pressure of 
1.6×10-6 mbar. Collision cross-section (CCS) measurements were made using known CCS 
values of avidin, ADH, and PK, as well as cytochrome c, concanavalin A tetramer, and 
glutamine dehydrogenase (Sigma-Aldrich), as calibrants using the method described 
previously.8,28 All mass spectra were calibrated externally using a solution of cesium iodide (100 
mg/mL) and were processed on Masslynx 4.1 software (Waters). Charge reduction effectiveness 
was determined using: 
 Eff (%) = qavg,Control − qavg,CRqavg,Control
 (2.1) 
where qavg,Control and qavg,CR  are the average charge state distributions (qavg) for control and 
charge reduced (CR) protein ions, and are calculated using: 
 qavg =
qi ×wii∑
wii∑
 (2.2) 
where qi is the charge on the ith charge state and wi is the signal intensity for the ith charge state. 
 
 45 
 
2.3 Results and Discussion 
Initial experiments in our laboratory were aimed at characterizing many different methods of 
charge reduction in terms of multiple figures of merit, some of which are unique to the IM-MS 
experiment.  For example, in order to successfully build model structures of multiprotein 
complexes, collision cross-section measurements of proteins in their compact state are usually 
preferred over measurements of unfolded forms because compact states are more facilely-related 
to solution-phase architectures.48  Although limited measurements have been performed to assess 
the influence of charge reducing ion-neutral chemistries on the structures of small monomeric 
proteins,38 no data is currently available that rigorously assesses the influence of such chemistries 
on the gas-phase quaternary structure of proteins or in comparison with the solution-phase 
additive approaches for charge reducing ions produced by ESI.  In addition to monitoring the 
gas-phase structure of the ions produced using various charge reduction protocols, we have 
evaluated charge reduction strategies in terms of two other figures of merit.  We define charge 
reduction ‘efficiency’ as the amount of charge reduction agent required to observe a given level 
of charge reduction.  Further, we define charge reduction ‘effectiveness’  as the ultimate extent of 
charge reduction observed, under a given set of experimental conditions, relative to control 
datasets (see Experimental section for details).   
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Figure 2-2a shows charge 
reduction effectiveness and 
efficiency data for the avidin 
tetramer (64 kDa) acquired using 
our two charge reduction 
conditions.  The plots presented 
show trends in the average 
protein charge state distribution 
(qavg) recorded under optimum 
instrument conditions for charge 
reduction (i.e., optimized 
acceleration voltages, see 
Experimental Methods) versus 
DBU solution concentration for 
gas-phase ion-neutral charge 
reduction ranging from 0.7-2.0 M 
(blue) and DBU solution additive 
concentration ranging from 10-20 
mM (green).  The data shows that 
the concentration of charge 
reducing agent, used either as a 
solution additive or nebulized 
into the source for ion-neutral 
 
Figure 2-2. Plots of average avidin (a) and ADH (b) tetramer 
charge state against the concentration of DBU used in 
nebulized base solutions (▲) and as an additive in protein 
samples (●).  Error bars shown for each measurements 
represent standard deviation calculations from average charge 
state measurements spanning at least three replicates.   In all 
cases, solution-phase additives exhibit higher charge reduction 
efficiencies (charge reduction per-unit of base concentration) 
and the use of nebulized base exhibits greater charge reduction 
effectiveness (ultimate charge reduction amount achieved).	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chemistry, is inversely correlated with the average protein charge state recorded for the avidin 
tetramer. In addition, while the solution additive approach exhibits substantially higher charge 
reduction efficiencies (charge reduction per-unit concentration of base utilized), ion-neutral 
charge reduction results in more effective charge reduction, evidenced by the lower average 
protein charge states achieved using this approach in Figure 2-2a.  Higher base concentrations 
added to protein complex samples in solution result in signal suppression and protein complex 
disruption (data not shown).   Similar trends are observed forthe alcohol dehydrogenase tetramer 
(144 kDa), and are shown in Figure 2-2b over the concentration ranges 0.7-2.0 M and 5-15 mM 
for in source gas-phase charge reduction (blue) and solution additive charge reduction (green), 
respectively.  Again, the solution additive approach is a substantially more efficient process with 
respect to the base utilized in the experiment, routinely producing significant charge reduction 
using 4 orders of magnitude less base than equivalent ion-neutral reaction chemistry approaches. 
Conversely, ultimate charge reduction effectiveness values for both avidin and ADH datasets 
respectively were calculated to be 22 and 11% for the solution additive protocol and 28 and 20% 
for the ion-neutral reaction chemistry approach. Similar trends are observed for protein complex 
charge reduction when other basic molecules are used (e.g., TEA and DBN, data not shown). 
Thus, while adding base molecules directly into protein complex samples is a more efficient 
means of charge reduction, nebulized base used for ion-neutral charge reduction following nESI 
is a more effective charge reduction method under the conditions used here.  
 The results recognize the metrics of charge reduction efficiency and effectiveness as 
critical measures that allow for the analytical comparison of charge reduction protocols in 
general. However, the influence of such approaches on the gas-phase structure and topology of 
protein complexes measured by IM-MS is arguably a more important criterion for assessing the 
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applicability of such methods for 
applications in structural biology.  Figure 2-
3a shows data for the avidin tetramer (64 
kDa) acquired using three experimental 
conditions. The red contour plot represents a 
control dataset, with no base added either in 
solution or in gas-phase. As the avidin 
tetramer is ionized and transferred into IM-
MS with minimal gas-phase activation, 
charge states corresponding to avidin 
tetramer center around 17+ with drift times 
that are consistent with compact native-like 
tetramers are observed by MS and IM 
respectively. In contrast, avidin tetramer 
ions produced from solutions with added 
◄ Figure 2-3.  Mass spectra (top) and drift 
time verses m/z contour plots (bottom) of (a) 
avidin, (b) alcohol dehydrogenase, and (c) 
pyruvate kinase.  Red spectra and contour 
plots correspond to control conditions, blue 
spectra and contour plots correspond to gas-
phase charge reduction conditions with DBU, 
and green spectra and contour plots 
correspond to solution additive charge 
reduction conditions with DBU.  We have 
acquired similar datasets where DBU is 
replaced with either DBN or TEA bases.  
Increased IM drift times observed on the 
contour plots corresponding to solution-phase 
additive datasets indicate protein complex 
unfolding relative to control and ion-neutral 
charge reduction data.	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DBU (20 mM) exhibits extensive charge reduction (green in Figure 2-2a). As described in 
previous reports, DBU (and other similar bases) adheres to the surface of proteins complexes in 
solution and subsequent nESI generates clustered ion-neutral complexes.  These ion-neutral 
clusters further desolvate such that the small basic molecules carry charge away from the protein 
complex ions, thus resulting in charge reduction.31 In our experiments with DBU and similar 
bases, a small amount of accelerating voltage is necessary to reduce charges during desolvation, 
presumably by promoting the dissociation of basic molecules from the complex through 
energetic ion-neutral collisions. For the data shown in Figure 2-3a, the ions were accelerated at 
150 V in the ion trap prior to the IM separation region of the instrument to produce maximum 
charge reduction, and similar results are achieved by applying activation voltage in the skimmer-
cone region of the instrument. While the activation voltage used is insufficient to cause the 
protein complex to dissociate, IM data reveals that the protein complex ions generated by adding 
base in solution undergo substantial unfolding under these conditions. In contrast, if the same 
basic molecules are nebulized into the ion source region of the instrument, charge reduction is 
observed in the absence of energetic collisions and the ions remain compact (blue dataset, Figure 
2-3a). Drift time spectra for each of the three ionization conditions are presented for the 14+ ion 
of avidin tetramer.  Control (red) and gas-phase charge reduced (blue) datasets correlate well, 
while solution additive charge reduction data (green) is shifted to longer drift times.  
Furthermore, drift time features are substantially broadened in solution additive data when 
compared with control datasets, and IM resolution is observed to decrease by approximately a 
factor of 2. 
Similar results to these are observed for other multiprotein complex ions.  Figure 2-3b 
shows data for ADH tetramer ions (144 kDa), where substantial unfolding is observed for the 
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more highly charged region of the charge state distribution produced from solutions with added 
DBU, and the ions exposed to nebulized DBU remain compact (drift time spectra shown for 22+ 
ions). While the conclusions reached for this dataset are similar to those for avidin, some 
differences are apparent. For example, ADH tetramer ions charge reduced using solution 
additives exhibit a larger degree of gas-phase unfolding than observed in avidin datasets.  In 
addition, the charge reduction effectiveness for ADH tetramer ions is observed to be 
substantially higher under the conditions used in Figure 2-3b than that observed for avidin 
datasets under similar conditions (27% for ADH versus 8% for avidin in Figure 2-3a). Similar 
observations are made in the case of PK (232 kDa) tetramer ions. The data shown in Figure 2-3c 
suggest that significant conformational changes occur for most of the PK tetramer charge states 
produced using the charge reduction method based on solution-additives (green). Similar to 
avidin and ADH, compact and ‘native–like’ PK IM data (drift time spectra show 29+ ion) is 
observed for complexes exposed to nebulized base after ionization. In some cases, activating 
ions to produce charge reduction following the addition of base in solution produces ion 
populations that are compacted relative to both control (red) and gas-phase charge reduced (blue) 
datasets. Such compaction effects have been observed for other protein complexes upon 
activation,13,49 and are consistent with collision-induced remodeling of the complex prior to gas-
phase unfolding. We also observe a larger mass increase for ions having undergone charge 
reduction using the ion-neutral chemistry approach when compared to the solution-additive 
approach described here. This observation is consistent with the more gentle, less activating 
conditions that are possible when base is nebulized into the source rather than added in solution 
(see the Experimental Methods section above for notes on instrument conditions for the two 
experimental protocols used here).   
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Collision cross-section 
(CCS) measurements for the 
ions observed in Figure 2-3 are 
generated using calibration 
procedures that involve a set of 
known ions having a broad 
range of ion mobility and CCS 
values, and are plotted as a 
function of charge state in 
Figure 2-4.28 Protein ions 
produced from gas-phase 
charge reduction generate CCS 
values similar to control in 
cases where charge states 
overlap (blue triangles and red 
diamonds respectively, Figure 
2-4). A small exception to this 
general observation is apparent 
in our PK dataset, where CCS 
values for ions generated using 
gas-phase charge reduction are 
1-3% smaller than equivalent 
ions generated from our control 
	  
Figure 2-4.  Collision cross-section (CCS) measurements verses 
charge state plots for (a) avidin, (b) alcohol dehydrogenase, and 
(c) pyruvate kinase, where ( ) indicate control conditions, (▲) 
indicate gas-phase charge reduction conditions with DBU, and 
(●) indicate solution additive charge reduction conditions with 
DBU.  Significant increases in CCS are observed for solution 
additive datasets compared with both control and ion-neutral 
chemistry charge reduction data. 
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protocol.  In contrast, for those ions produced by solution-phase additive approaches, large 
increases in CCS are observed in most cases when compared to ions produced using either the 
control or gas-phase charge reduction protocol (green circles).  For example, the 33+ charge state 
of PK, has a measured CCS from our control dataset of 10084 Å2. The same ion generated when 
DBU is nebulized into the ion source has a nearly identical CCS (10094 Å2, 0.1% different), 
while the 33+ ion measured after charge reduction from DBU added in solution is 16% larger 
than control (11684 Å2). This increase in CCS across most charge states further indicates protein 
unfolding upon activation, and confirms our analysis of the data shown in Figure 2-3.   Decreases 
in CCS of ions following charge reduction via solution additives are also observed in our dataset.  
Figure 2-4b shows data for the ADH tetramer, in which CCS decreases ~6% for the 18+ ions 
produced with solution additives relative to their counterparts produced by gas-phase ion-neutral 
chemistry.  Such decreases can also be a sign of collision induced remodeling of the protein 
complex topology.13,49 
For all protein complex ions generated in control and gas-phase charge reduction datasets, the 
trend observed in CCS as a function of charge state is near-linear, having a negative slope.  In 
addition, the observed slope is shallow, with the range of CCS values spanning less than 10% for 
all protein complexes produced by these two methodologies. As discussed above, the apparent 
compaction observed for protein complex ions as charge state is increased is similar to previous 
datasets,13,19,49 and is likely due to the enhanced kinetic energies, and thus internal energies upon 
collisional activation, of the higher charge state ions observed. Other plausible explanations for 
the slight decrease in CCS observed as a function of center on the calibration function used to 
convert traveling-wave IM drift times to CCS values using ions of known CCS.48 While the 
possibility of calibration errors cannot be completely eliminated from our analysis, our dataset 
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utilizes a recently developed database of calibrant values that span a large range of CCS and ion 
mobility values in order to minimize errors in the process28 and makes significant errors in 
calibration unlikely.       
Again, in contrast to datasets collected from ions produced from control samples or ion-neutral 
ion chemistry-based charge reduction, ions generated from solutions with basic additives result 
in significantly larger CCS values relative to control values and varying trends as a function of 
charge state. We have also collected data on concanavalin A tetramers (from jack bean, 103 kDa, 
data not shown), where the trends in CCS as a function of charge state are parabolic in nature, 
with the intermediate charge states exhibiting minimum CCS values.   It is possible that trends in 
CCS for protein complex ions as a function of charge state could be used to recover structural 
information from the assembly or as a means of protein complex identification, and these areas 
are an active area of research in our laboratory. Note also that in some cases, the addition of base 
in solution acts as a disrupting agent similar to the addition of organic solvent or salts, resulting 
in the formation of protein dimers and monomers in solution. This is the case with concanavalin 
A tetramers where solution additives cause the dissociation of tetramer into dimers while gas-
phase charge reduction approaches are able to retain the tetramer and reduce its charge. This 
further makes the case, in general, for gas-phase approaches to charge reduction, especially for 
more-fragile multiprotein complexes. 
2.4 Conclusions 
In this report, we demonstrate that the addition of strong bases (TEA, DBN, DBU) in solution, 
while leading to charge reduced populations of electrosprayed protein complexes, can also result 
in unfolded protein conformers in the gas phase through the activation necessary to dissociate 
proton-bound base molecules from the surface of the complex. It is important to note that while 
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operative for the base molecules studied here, gas-phase unfolding has not been observed in 
other cases where small molecules have been added in solution in order to charge reduce 
multiprotein complexes. For example, imidizole has been used to reduce the charge state of the 
GroEL tetradecamer and IM-MS data indicate a compact configuration for the charge reduced 
species generated.14  Similarly, crown ether compounds and triethylammonium acetate buffer 
have recently been used to alter the charge state of transthyretin tetramers in order to study their 
collision induced dissociation properties.21 Here again, IM-MS data confirm compact 
conformations for the charge reduced tetramers prior to activation. 
The critical differences associated with the base-protein complexes formed in our experiments 
likely relates to the stronger proton-bound interactions formed between highly-basic molecules 
and protein surfaces. These stronger interactions require increased energy to break, generated 
here in the form of activating collisions with inert neutrals. In addition to dissociating the 
protein-bound base molecules from the complex, the assembly unfolds in our experiments as 
well. This result is in stark contrast to those where the base is nebulized in the ion source and 
allowed to interact with the protein in the gas-phase through ion-neutral reaction chemistry. In 
these cases, base likely interacts with proteins in fewer numbers, and in a more discrete fashion, 
than the action of the same base molecules in solution.  This would  likely lead to fewer base 
molecules bound to the surface of the protein at any given time and, thus, the complexes created 
would require less thermal energy to dissociate and generate charge reduced species. Moreover, 
nebulization method is a more effective method since it produces ions that are more charge-
reduced compared to method employing bases additives in solution. In summary, our results 
suggest that gas-phase ion-neutral chemistry approaches offer an alternative method to reduce 
charges for protein complexes that is accessible to a larger number of basic molecules than 
 55 
 
equivalent approaches in solution, while having an enhanced ability to generate compact protein 
complex structures. 
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Chapter 3. Ion Mobility-Mass Spectrometry Reveals Highly-
Compact Intermediates in the Collision Induced Dissociation of 
Charge-reduced Protein Complexes 
Russell E. Bornschein, Shuai Niu, Joseph Eschweiler, Brandon T. Ruotolo, Prepared for 
submission to Journal of The American Society for Mass Spectrometry as Ion Mobility-Mass 
Spectrometry Reveals Highly-Compact Intermediates in the Collision Induced Dissociation of 
Charge-reduced Protein Complexes 
 
3.1 Introduction 
Protein complexes are critically-important targets for structural biology, as such macromolecular 
complexes drive the majority of key cellular process and are, thus, highly sought drug targets.1 In 
the post-genomic era, the rapid structural analysis of protein complexes, largely driven by 
advances in X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, has 
catalyzed many breakthroughs in human health.2 However, the limitations of such technologies 
for proteins that resist bacterial over-expression, are difficult to purify in large amounts, or are 
natively active within polydisperse ensembles necessitates the development of a broader suite of 
tools capable of protein complex structural analysis. Mass Spectrometry (MS) techniques readily 
offer rapid analysis of mixtures, and many techniques are available for probing the structures of 
protein complexes in solution.3 Among these, ion mobility-mass spectrometry (IM-MS) has 
proved useful for determining the overall size and coarse-grained structure of intact protein 
complexes through measurements carried out in the gas-phase.4-8  
 Model structures of protein-protein complexes that rely upon IM-MS data are typically 
constructed by first measuring the intact assembly using MS.9 This step is followed by various 
protocols aimed at disrupting the intact complex into subcomplexes, and eventually its 
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monomeric building blocks, as mass measurements of such species provides direct protein 
connectivity information.9 For three-dimensional modeling, cross-section values from IM 
measurements for the intact assembly, as well as all observed subcomplexes, are input into a 
restraint-guided search of theoretical protein topologies that satisfy all experimental constraints. 
The accuracy of the IM-MS measurements, as well as the number of subcomplexes observed 
during data collection directly influences the confidence level and information content of the 
models generated.10-12 Such IM-MS methods have recently been used to construct models of 
polydisperse heatshock proteins,13 ATP Synthase,14 the CRISPR-associated Cascade assembly,15 
amyloid-associated aggregates,16 and replisome-related complexes.17  
Of the information content typically required for IM-MS protein complex model 
generation, a comprehensive cross-section analysis of protein monomers that comprise the 
assembly is both an essential element and a bottleneck in current methodologies. For example, 
solution-phase disruption approaches for producing low charge state protein monomers for IM-
MS measurements is currently the dominant approach to the problem; however, such data 
collection requires extensive screening of solution conditions to remove subunit proteins from 
the assembly without significant remodeling or unfolding.9,12,18-23 An alternative method for 
generating IM information on compact protein subunits is through gas-phase dissociation.  The 
most direct route to compact product ion formation in the gas phase is currently surface induced 
dissociation (SID), where ion-surface collisions of protein complex precursor ions induces 
activation on a short timescale in a shattering-type mechanism to produce compact subcomplex 
product ions.24,25 For precursor ions having charge states produced under native MS conditions, 
collision induced dissociation (CID) produces highly charged, highly unfolded monomer ions 
along with stripped protein complexes at reduced charge states.26-28 Such unfolded protein ions 
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are not readily relatable to protein structures in solution, and are thus not easily used in the 
context of protein complex model construction.  CID of charge reduced protein complexes, on 
the other hand has been shown to eject compact subunits.29 The primary example of this CID 
pathway comes from charge-reduced tetrameric transthyretin (TTR) ions, which have been 
observed to produce both compact monomers and peptide ions at higher energies and lower 
charge states.29 Alternatively, charge amplification of stable boiling protein 1 (SP1) produces 
compact protein product ions following CID.30 In both cases, the mechanism of ion formation is 
currently obscure, but it is clear that greater control and understanding of the processes involved 
would catalyze an enhanced capability to model multiprotein structures using IM-MS.   
Methods for reducing analyte ion charge states range from simple solution manipulation 
approaches to more complex gas-phase ion-neutral and ion-ion reactions,31-39 with advantages 
and disadvantages for each. Solution-phase manipulation approaches for charge reduction have 
the advantages simplicity and efficiency, however, such protocols also often sacrifice native 
protein-protein interactions, as well as the overall effectiveness of the charge reduction 
process.31-33 Alternatively, gas-phase charge reduction approaches do not affect protein-protein 
interactions; however, require specialized instrument modifications and sacrifice molecular 
efficiency, in that charge reduction agents must typically be added in large excess to significantly 
reduce ion charge.33-39 
 Here we attempt to answer the underlying questions surrounding the formation of 
compact monomeric CID product ions from charge reduced protein complexes by studying 
avidin (64 kDa) and aldolase (157 kDa) tetramers. Using solution based charge reduction 
methods, we record collision induced unfolding (CIU) over a broad range of charge states to 
observe protein complex stabilities and unfolding patterns. Furthermore, we measure the 
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collision cross-sections (CCSs) of both parent and product ions produced by CID from each 
precursor charge state, as well as the charge state distribution (CSD) of the product ions formed. 
Current models of protein complex CID suggest that charge is equally distributed over all protein 
surface in the transition states accessed by the complex prior to dissociation, creating clear 
expectations for ratios of product ion/parent ion ratios of size and CSD. For both protein 
tetramers studied here, we observe ratios that that do not align with such expectations without 
invoking intermediate states that are compacted, and constructed of compacted monomers. In the 
case of aldolase, such states are directly observed, however for avidin they are inferred from 
CSD and product ion data alone, possibly suggesting an unstable, transient intermediate species 
not captured on the timescale of our IM-MS measurements. We then use CCS data as physical 
constraints to build models describing the CID pathways observed for these two protein 
tetramers and discuss their significance. 
3.2 Experimental 
3.2.1 Sample Preparation 
Avidin (chicken egg white) and aldolase (rabbit muscle) were prepared under native conditions 
in 200 mM ammonium acetate to a concentration of 10 µM following buffer exchange using 
Bio-Rad spin columns with a 40 kDa low mass cutoff (Hercules, CA, USA). Charge reduced 
states were achieved under two different protocols; either by buffer exchanging and diluting 
protein samples into triethylammonium acetate (TEAA) or by addition of the charge reducing 
agent triethylamine (TEA), and in some cases TEAA, at various low concentrations to samples 
prepared in ammonium acetate.32 All proteins, buffers, and charge reducing agents where 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
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3.2.2 Instrumentation and Data Analysis 
IM-MS experiments were performed on a commercial quadrupole-traveling wave ion mobility-
time-of-flight mass spectrometer (Q-TWIM-TOF MS) instrument purchased from Waters 
(Synapt G2 HDMS, Manchester, UK). IM-MS data was analyzed using MassLynx software and 
CCSs were measured using standard calibrants following a previously published protocol.13,40,41 
CIU and CID experiments were performed by increasing the collision energy in the “Trap T-
Wave” region of the instrument, after quadrupole mass selection and prior to IM separation. Data 
were acquired at 5V intervals over a voltage range that allowed all charge states of a protein to 
be studied over the same laboratory-frame energy range (i.e., tetramer charge state × trap 
collision energy voltage). 
 Protein unfolding was assessed using CIU “fingerprints”, which are generated by plotting 
intensity normalized drift time chromatographs into 3D contour plots of CCS verse lab-frame 
collision energy. To record CIU threshold energies, the CCS of the most abundant peak was 
identified at each collision energy. From these CCSs the smallest CCS (at energy E1) was 
identified and all CCSs 2.5% greater than the smallest CCS were selected. From this list the CCS 
with the lowest energy (at energy E2, where E1<E2) is chosen and is defined as the CIU energy 
threshold. Similarly, CID energy thresholds were measured from MS data, and are defined as the 
energy at which the greatest positive difference in relative product ion intensity between adjacent 
5V steps is observed. 
3.2.3 Molecular Modeling 
Simulated monomer structures for avidin and aldolase were built starting from the known protein 
complex X-ray crystal structures (1AVE and 1ADO, respectively).42,43 A single monomer 
subunit, extracted from the intact tetramer, was assigned charge evenly over its surface on the 
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most basic residues (Lys, Arg, His and N-terminus). All the molecular dynamics simulations 
were performed using the GROMACS[44] software package (ver. 4.5.5)44[B. Hess and C. Kutzner 
and D. van der Spoel and E. Lindahl] under a GROMOS96 53a6 force field.45 The system was 
energy-minimized by the steepest decent method, and then went through an nvt and subsequently 
an npt simulation. The monomeric protein was then subjected to simulated annealing where the 
system temperature was varied from 300 K to 800 K then cooled back to 300 K in a periodic 
manner for 50,000 iterations over the course of a 20 ns simulation, in order to allow for escape 
from local minima and enhance equilibration. Every 5th 300 K structure was recorded (producing 
10,000 total structures) throughout the simulation.46,47 From these structures, the most compact 
model with the lowest potential energy, which also agreed with experimental CCS measurements 
(as computed using a scaled projection approximation in MOBCAL and IMoS),48,49 was selected 
for further model building of tetramers with native-like geometries. To model tetramers with 
rearranged structures, spherical representations of compact monomers with CCSs equal to 
experimental measurements were docked to a trimer subunit (built from compact monomer 
spheres) of appropriate CCS and the conformational space was sampled with an exhaustive 
Monte Carlo search.10 In the case of coarse-grained structures, CCS values were computed using 
a projection approximation, as described previously.10,11 Final structures are selected based on 
agreement with experimental size (CCS) constraints and acceptable spherical overlap (15-
45%).10 
3.3 Results and Discussion 
The native charge states of aldolase (23+-27+), generated from ammonium acetate, and those 
produced via charge reduction (17+-22+) were measured over a collision energy range that 
included 540 eV-3600 eV (with the exception of 17+, for which our dataset has an upper limit of 
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3400 eV). Over this energy range, all protein charge states undergo structural transitions and 
dissociation. Figure 3-1A presents CIU fingerprints for 4 aldolase charge states (for all 11 CIU 
fingerprints see Appendix C Fig. C-1). Overlaid on these plots are dashed white lines, which 
represent the CID threshold measured for each ion. The CIU data recorded for the five charge 
states observed from unmodified ammonium acetate solutions are all very similar; each ion 
unfolds extensively prior to the onset of dissociation, with higher charge state ions adopting a 
greater number of meta-stable conformational states, but always trending towards a more 
 
Figure 3-1. Representative CIU fingerprints (A) and comparison of CID and CIU threshold energies 
for aldolase. Dashed lines in CIU fingerprints represent CID energy thresholds. (B) CID (u) and CIU 
(n) energy thresholds for measured tetramer charge states, along with the average monomer charge 
states (p, right y-axis) produced during CID. (C) Laboratory-frame collision energy differences are 
plotted between the CID and CIU thresholds. A negative difference value indicates monomer 
dissociation prior to tetramer unfolding.	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extended conformation. A transition in the protein’s unfolding pathway becomes apparent 
beginning with the 21+ ion, where a compacted conformational state is observed at lower 
energies compared to those that elicit monomer unfolding.  This protein complex compaction is 
enhanced and observed over a broader range of energies as lower charge states are evaluated, 
mirroring previous work with cavity-bearing protein complexes.50 Ultimately, the 17+ produces 
an unfolded conformation with a CCS smaller (1.5%) than the low energy CCS of the intact 
complex due to extensive compaction at lower energies (4.1%). 
Further evidence of a shift in dissociation pathway is indicated by the CID threshold 
energy for each aldolase precursor ion selected for CIU. As shown in Figure 3-1B, there is a 
general increase in the CID threshold energy value (purple) as the charge state decreases from 
27+ to 21+. However, this trend breaks down for lower charge states, where a significant decrease 
in the threshold energy is observed. It is important to note that this shift in threshold energy is 
isoenergetic with the tetramer compaction observed for the aldolase tetramer at lower charge 
states. As observed in Figure 3-1A, CIU threshold energy increases with decreasing tetramer 
charge state (Fig. 3-1B, blue). The expected asymmetric protein complex dissociation pathway is 
expected to exhibit significant unfolding prior to complex dissociation, and this is observed 
experimentally by plotting the difference between the CID and CIU thresholds observed as a 
function of tetramer charge state (Figure 3-1C). Higher charge states exhibit a positive difference 
supporting an asymmetric, protein-unfolding centric dissociation pathway. However, the energy 
difference for lower charge states (19+-17+) is negative, indicating that a significant population of 
product ions are likely produced from a compacted tetramer precursors, having undergone no 
significant unfolding. 
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Also plotted are the average monomer product ion charge states observed in our dataset 
(Fig. 3-1B, red). We record a decrease in product ion charge state with decreasing tetramer 
precursor charge state. However, we note that the average percentage of the total precursor ion 
charge transferred to the monomer product ions decreases only modestly over the range of ions 
studied here, ranging from 60% charge migration on average for the monomers from 27+ 
tetramers to 46% charge migration on average for those monomers produced from 19+ 
precursors, with similar values recorded for 18+ and 17+ tetramers as well. Taken together, the 
data in Figure 3-1 point to a shift in the dissociation pathway that likely occurs between the 22+ 
and 19+ charge states, characterized by a compacted tetramer transition state, and leads to a lower 
energy dissociation thresholds.  
 The native charge states of avidin (15+-17+), generated from protein prepared in 
ammonium acetate, as well as those produced via charge reduction (11+-16+), were measured 
over a laboratory-frame collision energy range of 540 eV-2400 eV (with the exception of the 
11+, which has an upper limit of 2200 eV in our dataset). Over this energy range all charge states 
under go structural transitions and dissociation. Figure 3-2A shows CIU fingerprints for 4 avidin 
charge states (for all 7 CIU fingerprints see Appendix C Fig. C-2). Overlaid on these plots are 
dashed white lines, which represent the CID threshold characterized in the same manner as for 
the aldolase data described above. The three charge states observed for proteins generated from 
pure ammonium acetate solutions are very similar; each ion unfolds extensively prior to the onset 
of dissociation, with the transitions from compact, to intermediate, to extended state similar to 
both aldolase and previously reported data.29 A transition in CIU is apparent at the 14+ ion (see 
Appendix C Fig. C-2) indicated by a significant decrease in number of unfolded conformational 
states observed. This observation extends to all ions of lower charge. Unlike aldolase, the CIU 
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data for low charge states of avidin does not reveal any significant compaction within the intact 
tetramer.   
 In further contrast to our aldolase dataset, Figure 3-2B shows a much different general 
trend for CID and CIU threshold energies, where values decrease continuously in the case of 
avidin across the entire charge state range studied. In addition, the charge states acquired by 
monomer product ions are observed to decrease in a near-linear fashion as a function of 
decreasing precursor ion charge state, and the energy required for CIU does not exceed that for 
CID in our avidin dataset, both in contrast to the non-linear transitions and trends observed for 
 
Figure 3-2. Representative CIU fingerprints (A) and comparison of CID and CIU threshold energies 
for avidin. Dashed lines in CIU fingerprints represent CID energy thresholds. (B) CID (u) and CIU 
(n) energy thresholds for measured tetramer charge states, along with the average monomer charge 
states (p, right y-axis) produced during CID. (C) Collision energy differences are plotted between the 
CID and CIU thresholds. The CIU threshold for 11+ (Ü) was not observed, and in its place we show a 
point at the highest attainable laboratory frame energy on our instrumentation for illustrative purposes. 
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aldolase above. Both data are in good agreement with previous CIU/CID data for TTR, where a 
general mechanism absent of any precursor structure transitions was invoked to explain the IM-
MS data collected as a function of charge state.29 
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 Current models of the protein complex CID pathway, that describe how unfolded 
monomers as well as stripped, charge-reduced protein complexes are produced as product ions, 
require that charge is equally partitioned over the surface area of the unfolded transition states 
accessed by the assembly during activation.51 This requirement produces several testable values 
that can be extracted from our aldolase and avidin datasets. The first, is the ratio of the monomer 
product ion size to the tetramer precursor ion size (monomer CCS/tetramer CCS, expressed as a 
% of tetramer CCS), and the second is a ratio of monomer and tetramer precursor charge state 
(CS). Figure 3-3 plots these two metrics against each other for data acquired for aldolase (Figure 
3-3A) and avidin (Figure 3-3B), along with idealized ratios of CCS values, represented as 
horizontal dashed lines, derived from models described below. The relative number of ions that 
account for each point in the diagram is represented by the relative size of that point within the 
plot. In general, we observe a positive trend for both assemblies, in that protein charge 
asymmetry general increases with increasing size asymmetry (e.g., from monomer unfolding). 
The differences we observe between the two datasets shown in Figure 3-3, however, far 
outweigh their similarity. For example, the aldolase data shown in Figure 3-3A can be 
approximated by a single, near linear trend line, whereas there is a clear discontinuity for the 
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avidin in the data shown in Figure 3-3B. In 
addition, when compared with idealized CCS 
ratios between X-ray derived monomers and 
tetramers, which should function as a lower-
limit to the size differences recorded provided 
X-ray structures are preserved in the gas-phase 
during activation, the majority of aldolase 
values are greater (83.1%), while 59.7% of 
avidin data points lie below such a threshold.  
 In order to develop models of avidin and 
aldolase that account for a larger proportion of 
the data acquired than those derived from 
	  
t  Figure 3-3. Plots of Monomer/tetramer CCS 
ratio versus monomer/tetramer charge state (CS) 
ratio for (A) aldolase and (B) avidin, and (C) plot 
of avidin timer CCSs produced during CID. Data 
point sizes are scaled relative to observed product 
ion signal intensities. (C) Plot of measured 7+ 
avidin trimer product ion CCSs versus laboratory 
frame collision energy for 17+ and 11+ tetramer 
parent ions. Dashed red lines on panels A and B 
represent monomer/tetramer size ratios from X-ray 
data and the trimer CCS computed from X-ray data 
for panel C. Dashed orange lines on panels A and B 
represent the monomer/tetramer size ratio 
computed from a compact, native-like model 
computed following relaxation of the structure in 
the gas-phase and on panel C, the trimer size 
computed similarly. Dashed blue lines represent the 
monomer/tetramer size ratio from a compact 
rearranged model (panel B) of avidin and the avidin 
trimer size from a compact rearranged model 
(panel C, see supporting information). 
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unmodified X-ray structures, we began by building putative models of intermediate tetramer 
structures based on the compacted portion of our CCS dataset. Such models, once generated, 
would act to alter the monomer/tetramer CCS ratios that we project on to the plots shown in 
Figure 3-3A and 3-3B. In the case of aldolase, data shown in Figure 3-1 clearly shows the 
evidence of tetramer compression, especially in cases where lower charge states are studied. To 
build representations of such a compacted aldolase tetramer, we subjected the crystal structure of 
an aldolase monomer to simulated annealing in the gas phase producing a compacted monomer 
structure in good agreement with experimental CCS measurements. We then constructed an 
aldolase tetramer using the compacted experimental CCS as a constraint, but keeping the 
symmetry and quaternary organization of the monomers similar to those found in the crystal 
structure. To build this model, it was necessary to minimize the number of contacts between 
adjacent monomers, thus likely weakening the interactions between individual aldolase units. 
The dashed orange line in Fig. 3-3A represents the size ratio found in this “Compact Native-like” 
structure, and projects a CCS ratio value lower than 91.2% of our experimental data.   
Models for a compacted avidin tetramer are more problematic to conceptualize, as we 
collected no direct evidence of tetramer compaction in our CIU data shown in Figure 3-2A. To 
constrain a compacted tetramer model, we recorded CCS values for stripped trimer ions 
produced from CID (Figure 3-3C). We were able to observe such trimer product ions from 
multiple avidin precursors, and all ions observed possess a smaller CCS value than any X-ray 
derived trimer (red dashed line, Figure 3-3C). Due to the comparatively low CID efficiency 
observed for charge reduced aldolase tetramer ions, we are unable to record CCS values for 
aldolase trimer product ions in a similar manner. Using experimental measurements of compact 
avidin monomers, a coarse-grained symmetrical trimer geometry was generated, and found to 
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agree well with experimental trimer CCS values (2385 versus 2381 Å2). Following this 
optimization, a exhaustive Monte Carlo search was performed to develop a model of the avidin 
tetramer based on restraints derived from the compacted trimers and monomers observed as 
product ions, along with the ‘native-like’ tetramer size recorded for all low charge state ions in 
Figure 3-2A. Models that satisfy the monomer and trimer experimental CCS restrains and have 
sufficient spherical overlap between subunits to indicate physical interaction (>15%) have 
tetramer CCSs that are well below experimental CCS measurements (6% smaller for the model is 
closest agreement; see Appendix C Table C-1). Alternatively, models that satisfied experimental 
restraints for monomer, trimer, and tetramer CCS were found to be unphysical, showing 
spherical overlap of 2.6%, well below the threshold for biologically relevant contacts (15%). 
This result implies that a compacted avidin intermediate must be transient on the timescale of our 
IM measurement, leading to a form of the protein complex that produces monomer and trimer 
product ions that possess charge states and sizes that align with our data, but does not possess an 
intact CCS resembling the values recorded directly for the avidin tetramer. During this process, 
we also constructed an avidin tetramer model in a similar fashion to those we built for aldolase. 
Both of these models, when projected onto Figure 3-3B, account for a significantly larger portion 
of the data collected for avidin CID product ions when compared with those values extracted 
directly from unmodified X-ray coordinate files, with a simple compacted model (Figure 3-3B, 
dashed line in orange) accounting for a larger portion of the data (93.5) than a model that 
includes rearrangements that account for our avidin trimer size measurements (91.9%; Figure 3-
3B, dashed line in blue).    
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3.4 Conclusions 
Within the gas-phase, multiprotein complex ions retain native-like conformations and can be 
studied using IM-MS.5,6 With additional subunit and subcomplex IM-MS size measurements, 
where the subunits and subcomplexes also retain a semblance of their native-like, intra-complex 
conformations, coarse-grained and hybridized models of the complex structure can be 
produced.10-12 Traditional methods of disrupting complexes in solution are not universal, and 
require extensive screening to produce optimized solution conditions.9,23 Gas-phase dissociation, 
having a more universal pathway, is desirable for its broad application; however, native-like 
monomer conformations are not retained in the gas-phase.26-28 Under charge reducing conditions 
evidence of compact monomer dissociation, ideally suited from building model structure, has 
been demonstrated for the TTR tetramer.29 Here, we show evidence for two additional proteins, 
aldolase and avidin, producing compact gas-phase monomers following collisional activation of 
charge reduced ions. 
Collision induced dissociation and unfolding of charge reduced ions of aldolase and 
avidin confirms the ability to induce dissociation of proteins prior to unfolding, consistent with 
previous data. Data presented here shows aldolase undergoing tetramer compaction on the 
experimental timescale prior to dissociation of compacted monomers. Both of these compact 
gas-phase conformations are smaller than expected based on predicted values from crystal 
structures. Simulated annealing of the monomer generates compact monomers with sizes that 
agree with experimental measurements. The size of tetramers build from compact monomer, 
where a native-like geometry is maintained, also agrees with experimental measurements. Avidin 
tetramer, unlike aldolase, maintains a constant size until the onset of unfolding. However, like 
aldolase, dissociation produces compact monomers, in addition to compact trimmers, with 
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smaller sizes than predicted from crystal structures. Like aldolase, simulated annealing of the 
avidin monomer produced compact conformations with sizes in good agreement with 
experimental measurements. Tetramers build from compact monomers with a native-like 
geometry were also in good agreement with experimental measurements, but the trimer sizes was 
not. A coarse-grained trimer with a rearranged symmetric geometry was build to agree with 
experimental size measurements. A Monte Carlo search of potential monomer-trimer 
conformations generated tetramer conformations with minimal subunit interaction while still 
maintaining physical interactions; however; the size did not agree with experimental values. 
From these models we infer the existence of a compacted transient species conformation that is 
unobservable on the experimental timescale. 
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 Figure 3-4 presents the two distinct pathways for unfolding and dissociation taken by 
aldolase and avidin. Under the purple pathway (left), aldolase undergoes tetramer compaction to 
produce gas-phase species with compact CCSs. Dissociation of this compact tetramer produces 
compact product ions (trimer, marked by Ü, was not observed due to low dissociation 
efficiency). Under the red pathway (right), avidin tetramer maintains a constant CCS up until the 
point of dissociation. Compact, rearranged transient species, not observed on the timescale of the 
experiment, exist as the immediate precursor to complex dissociation. Dissociation proceeds 
from the transient compact species to generate compact product ions. Explanations for 
differences between the two proteins are being explored to understand the observation of two 
distinct pathways. The compaction of aldolase observed during CIU strongly resembles 
 
Figure 4. Proposed dissociation pathways for aldolase (purple) and avidin (red). Both systems 
produce compact product ions through compaction of the tetramer prior to dissociation. The key 
differences between the two systems are the lifetime of the compact species, and potential remodeling 
of the quaternary structure of avidin in the transient compact state.  The lifetime of the compact avidin 
species is proposed to be so short that it cannot be observed on the timescale of our IM-MS 
experiment. Aldolase trimer (Ü) was not measured due to low CID signal intensity for charge reduced 
precursor ions.	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compaction of charge reduced multiprotein complexes with ring-like conformations.50 However, 
aldolase does not exist in a ring-like conformation. Avidin is known to have particularly strong 
intermolecular interactions and falls in the ‘dimer of dimers’ class of tetramers.23 The unfolding 
data for avidin strongly resembles TTR,29 which is also a dimer of dimers.52 We postulate that 
this dimer of dimers conformation is a driving factor in the observed dissociation pathway, and 
warrants further investigation. 
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Chapter 4. Ion Mobility-Mass Spectrometry Reveals General 
Trends in the Gas-phase Ejection of Compact Subunits from Intact 
Protein Complexes 
Bornschein RE, Ruotolo BT, Prepared for submission to Analyst as Ion Mobility-Mass 
Spectrometry Reveals General Trends in the Gas-phase Ejection of Compact Subunits from 
Intact Protein Complexes 
 
4.1 Introduction 
Macromolecular protein complexes play a critical role in carrying out most of the key functions 
within the cell, from synthesis to cell death.1 The quaternary structures of these multiprotein 
machines, therefore, are key targets for structural biology, in that such information can often lead 
to breakthroughs in human health and disease treatments.2,3 High-resolution methods aimed at 
the direct collection of protein structure information, such as X-ray diffraction (XRD) and 
nuclear magnetic resonance (NMR) spectroscopy, are often limited by stringent sample 
requirements in terms of purity, amount, protein flexibility, and assembly polydispersity.4 
Multiple mass spectrometry (MS) techniques are poised to overcome many of these challenges to 
develop lower-resolution protein complex models across the proteome in a high-throughput 
fashion.5 Approaches such as ion mobility (IM),6,7 chemical cross-linking (CXL),8,9 and 
hydrogen/deuterium exchange (HDX),10-12 when coupled to MS, have the ability to probe protein 
secondary, tertiary, and quaternary structure in addition to primary structure, thus enabling the 
generation of models of protein architecture in cases where classical structural biology tools 
provide little information.  
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 Ion mobility-mass spectrometry (IM-MS) is unique amongst the technologies listed 
above, in that protein structures are probed entirely in the gas-phase. Experimental evidence has 
demonstrated that native-like gas-phase conformations can be retained during nanoelectrospray 
ionization (nESI) when neutral pH, volatile aqueous buffers are used as solvents.6,13-15 From IM-
MS data, both stoichiometry and size (via measured collision cross-section; CCS) information 
can be determined and used to build low-resolution coarse-grain model structures of multiprotein 
assemblies.16-18 However, in order to build these coarse-grain topology models, subunits and 
subcomplexes must be measured in the gas-phase, and these assemblies must possess native-like 
conformations that are strongly-correlated with solution structures. Disruption of multiprotein 
complexes can be initiated in solution, through the alteration of ionic strength, solvents 
composition, and pH.19,20 While such approaches are currently the most reliable and broadly 
applied method for generating structurally-informative subcomplexes for protein complex model 
construction, broad application of solution-phase disruption IM-MS is currently hampered by an 
incomplete mechanistic understanding of subcomplex formation and protein-dependant 
responses to specific disruption agents.15,18,19,21-23 Alternatively, gas-phase dissociation methods, 
such as collision induced dissociation (CID)24 and surface induced dissociation (SID),25 are a 
promising class of techniques that potentially enable the targeted, universal production of 
subcomplex information for protein complex modeling efforts. However, for the vast majority of 
protein complex ions, CID usually results in the generation of highly-unfolded monomeric 
product ions following an asymmetric charge partitioning mechanism, where the monomer 
carries a disproportionate amount of the parent ion charge relative to mass.26-28 IM measurements 
for such ions are not typically useful for building protein structure models, and thus controlling 
81	  
 
the conformation of product ions produced from intact protein assemblies is a challenge for gas-
phase structural biology.28 
 Recently, CID of charge-reduced protein complexes was observed to produce compact, 
native-like monomer product ions.29 Under such conditions, CID products can be used for 
building topology models.29 Previous studies of this altered CID pathway have all been 
conducted using solution-phase charge state manipulation techniques, which ultimately limits the 
number of compact protein charge states screened, as well as covering a relatively limited set of 
protein complexes. To fully utilize such CID CCS information for high-throughput structural 
biology, the level of charge reduction necessary to alter the CID pathway toward the ejection of 
compact protein building blocks must be comprehensively characterized in order to generate 
predictive trends. Previously, we described a continuous gas-phase ion-neutral charge reduction 
source,30 and observed compact charge reduced protein complexes formed by a process that was 
both more effective but less efficient than those generated by solution-phase and ion-ion 
approaches.  
 Here, we adapt a recently-described corona discharge probe (CDP)31 to broadly and 
efficiently study the amount of charge reduction necessary to alter the CID pathways of protein-
protein complexes. We find a positive correlation between the threshold charge required to 
generate compact product ions from CID and the intact molecular mass of the precursor ion 
selected, for a broad array of protein complexes.  In addition, we discover that for the β-
galactosidase and catalase tetramers, the energetic barriers associated with peptide bond 
dissociation become either lower or iso-energetic than those associated with compact protein 
ejection for charge-reduced protein complexes. We analyze and discuss these results in light of 
their general utility for protein complex structural analysis. 
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4.2 Experimental 
4.2.1 Sample Preparation 
Ammonium acetate and triethylammonium acetate (TEAA) were purchased from Sigma Aldric 
(St. Louis, MO). Aldolase (rabbit muscle, tetramer 157 kDa), avidin (chicken egg white, tetramer 
64 kDa), β-galactosidase (β-Gal; E. coli, tetramer 466 kDa), β-lactoglobulin (β-Lac; bovine, 
monomer 18.6 kDa and dimer 37 kDa), catalase (bovine, tetramer 233 kDa), concanavalin A 
(ConA; jack bean, tetramer 103 kDa), cytochrome c (CytC; equine, monomer 12.3 kDa), 
hemoglobin (Hgb; bovine, dimer 32.4 kDa and tetramer 64.8 kDa), serum amyloid P (SAP; 
human, pentamer 125 kDa), and triosephosphate isomerase (TPI; rabbit muscle, dimer 53.3 kDa) 
were all purchased (Sigma Aldrich) as lyophilized powder. Stock samples were prepared into 
ammonium acetate at various concentrations. CytC was prepared to a final concentration of 10 
µM in 49.5% water:49.5% methanol:1% trifluoroacetic acid (TFA). All other proteins were 
prepared to a final concentration of 10 µM (with the exception of TPI which had a final 
concentration of 20 µM) in 200mM ammonium acetate following buffer exchange using Bio-Rad 
spin columns (Hercules, CA, USA). Alcohol dehydrogenase (ADH; yeast, 153 kDa), glutamic 
dehydrogenase (GDH; bovine, 336 kDa) and pyruvate kinase (PK; rabbit, 237 kDa) were also 
prepared for collision cross-section (CCS) calibration. 
4.2.2 Instrumentation and Data Analysis 
Ion mobility-mass spectrometry (IM-MS) experiments were performed on a commercially 
available Waters Synapt G2 HDMS (Manchester, UK) platform with a modified nESI source for 
performing gas-phase ion-ion charge reduction (see below). IM-MS data was processed using 
MassLynx and Driftscope software (Waters) to measure unknown CCS values following an 
established protocol32 using calibrants of known CCS values.33 
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Definitions of charge reduction efficiency and effectiveness used here are identical to 
those described previously.30 Briefly, charge reduction efficiency refers to the amount of charge 
reduction agent required to reduce protein ion charge states by a fixed amount, whereas charge 
reduction effectiveness refers to the ultimate amount of charge reduction observed under any set 
of conditions tested. To determine CID thresholds, the relative parent ion and product ion 
intensities were evaluated at each collision energy. The CID threshold is defined by the energy at 
which the product ion intensity reaches 50% (or 50% of the steady state intensity). To determine 
collision induced unfolding (CIU) thresholds, the drift time of the most abundant peak is 
identified at each collision energy. The CIU threshold is defined by the energy at which the drift 
time of the most intense peak is 2.5% longer than the shortest observed drift time. CID and CIU 
threshold are screened simultaneously across analyte charge states to identify the charge state at 
which the CID and CIU thresholds converge to the same energy, or invert when the CID 
threshold occurs at a lower energy than the CIU threshold. 
4.2.3 Corona Discharge Charge Reduction 
A CDP for performing gas-phase ion-ion charge reduction was constructed based on a previously 
described design.31 Briefly, a steel tube with a plastic cuvette attached to one end was mounted 
onto the nESI source housing in-line with the sampling cone, where the cuvette end is nearest the 
cone. Mounted to the open end of the cuvette is a grounded 0.5 mm thick stainless steel plate 
with a 1.5 mm aperture. Contained in the steel tube is a PTFE tube (0.030 inch i.d., 1/16 inch 
o.d.; Fisher Scientific) containing a 0.368 mm diameter platinum wire (Fisher) with one end 
ground to a fine point. The fine-point end of the platinum wire is positioned in a point-to-plane 
geometry with the stainless steel plate at a distance of 1.5-2.5 mm. The other end of the platinum 
wire is connected to a negative high-voltage power supply (Stanford Research Systems, 
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Sunnyvale, CA) through a 25 MΩ resistor (Newark Ohmite, Chicago, IL). Nitrogen gas is teed 
into the PTFE tubing through a PEEK tee (Fisher). The external surface of the stainless steel 
plate was positioned approximately 1.5 cm from the sampling cone. Gas pressure and applied 
voltages were varied between 60 to 90 psi and -6500 to -8500 V, respectively. 
4.3 Results and Discussion 
4.3.1 CDP-nESI Source Optimization 
Samples containing denatured CytC were used to optimize CDP conditions for maximum charge 
reduction while maintaining signal intensity. Screened variables include CDP gas pressure, 
applied voltage, sampling cone voltage and source backing pressure. Representative, optimized 
MS data from these screens are shown in Figure 4-1. Higher CDP pressures (Figure 4-1a) and 
voltages (Figure 4-1b) resulted in greater shifts in charge state distributions (CSDs) to lower 
charge states but at a significant cost to signal intensity, while lower pressures and voltages 
produce less significant shifts in CSDs with little cost to signal intensity. To balance the shift in 
CSDs with ion transmission, the gas pressure and applied voltages were optimized to 70 psi and  
-7250 V, respectively. Lower charge states are characterized by broad MS peaks with higher 
mass shifts, likely to due to anion attachment from the CDP. To promote collisional cleaning, 
mild in-source activation was applied by raising the sampling cone voltage and lowering the 
backing pressure. Higher sampling cone voltages had little effect on signal intensity, and was 
therefore optimized to the maximum value of 200 V to aid in adduct reduction. Backing pressure 
(Figure 4-1c) proved to have a significant effect on both the CSD and the level of adduction. For 
studying intact protein complexes, lower backing pressures had a significant effect on signal 
intensity, and therefore pressure was optimized at approximately 7 mbar for such larger ions. 
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 Under the conditions described above, the extent of charge reduction for intact protein 
complexes was assessed. Figure 4-2 presents optimized data from these screens (for additional 
proteins see Appendix D Figures D-1 to D-6). Under control nESI conditions, β-Lac (Figure 4-
2a) the most intense peaks for the monomeric and dimeric form of the protein correspond to the 
7+ and 12+ charge states, respectively. Using the optimized charge reduction conditions described 
above, the most intense peaks for β-Lac shift to the 5+ and 9+ charge states for monomer and 
dimer, respectively, with the lowest observed charge states being 4+ for both monomer and 
dimer. In the case of the TPI dimer (Figure 4-2b), the lowest charge state shifts from 13+ to 8+ 
upon activation of the CDP, while the most intense peak remains constant at the 15+ charge state. 
Similarly, for the SAP pentamer (Figure 4-2c), while the most intense peak remains the 24+ 
 
Figure 4-1. Mass spectra for denatured cytochrome C under various charge reduction conditions. In 
order to find the optimal conditions, under various (a) probe voltages with probe pressure held at 70 
psi, (b) probe pressures with voltage held at -7250 V, and (c) source backing pressures with the probe 
voltage and pressure held at -7250 V and 70 psi, respectively. At higher probe voltages and pressures, 
greater levels of charge reduction are observed with decreased signal intensity. A compromise 
between charge reduction effectiveness and signal loss is made using the optimized conditions of -
7250 V and 70 psi. At lower source backing pressures with sampling cone voltage at 200 V, in-source 
activation aids in stripping neutral and charge adductions, producing spectra with higher intensity 
peaks at lower charge states at higher resolution. To reduce structural effects due to in-source 
activation, the source backing pressure is raised to approximately 7 mbar for all intact protein 
complex, while maintain a sampling cone voltage of 200V. 	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under both conditions,  the lowest observed charge state shifts from 22+ to 11+ when the CDP is 
activated. Interestingly, we observe a minor increase in the most intense charge state for β-Gal 
tetramer (Figure 4-2d), which shifts from 47+ to 49+ upon CDP activation, however, the lowest 
observed charge state decreases as expected, from 44+ to 36+. While these data demonstrate some 
differences in the CSD shifts observed, all protein show significant charge reduction with respect 
to their lowest charge states using the CDP. Structural effects from in-source activation used to 
aid in charge stripping were monitored through comparison of CCS measurements to traditional 
native MS conditions (see Appendix D Table D-1). While high charge states did display 
evidence of unfolding, the low charge state ions of interest did maintained compact 
conformations throughout the ionization process.  Furthermore, our optimized conditions appear 
effective for different complexes, across a broad range of masses (18.6 to 466 kDa) and 
assembly stoichiometries (monomers to pentamers). 
 While TEAA addition in solution was, overall a more effective method of charge 
reduction when compared with the CDP source used in these studies, we observed two examples 
where CDP was the more effective approach. For example, we observe the 11+ charge state of 
the avidin tetramer using TEAA in solution (see Chapter 3), while 8+ ions were generated using 
the CDP source (see Appendi D Fig. D-1). Similarly, using TEAA to charge reduce aldolase 
generated 17+ ions (see Chapter 3) but using the CDP generated 14+ ions (see Appendix D Fig. 
D-2). Despite minor limitation, therefore, we find the CDP approach to be a generally flexible 
and effective approach toward protein complex charge reduction, which provides a universal 
approach capable of reducing the charge state of a broad range of assemblies, independent of 
their stabilities in solution.   
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Figure 4-2. Mass spectra from (a) β-lactaglobulin, (b) triosephosphase isomerase, (c) serum amyloid 
P, and (d) β-galactosidase with (top) and without (bottom) corona discharge probe turned on. The 
corona discharge probe has little effect on the charge state of the most abundant peaks across all 
complexes. The lowest charge states shift dramatically due to charge reduction, and in the case of 
SAP, the lowest charge state decreases by ten charges.	  
88	  
 
4.3.2 Detecting the Dissociation of Compact Subunits 
We used the optimized CDP conditions described above to screen the CID and CIU responses 
for a range of protein complexes in order to determine the charge states at which the CID 
threshold precedes the threshold for CIU. By definition, ions that undergo CID from states that 
do not unfold must eject product ions that are similarly compact. During the course of our 
experiments, we assessed the relative stability of ions produced by charge reduction in solution 
using TEAA against those produced by CDP. In general, we found them to be equivalent, as 
shown for the 12+ charge state of the avidin tetramer (see Appendix D Fig. D-7).  
 To rapidly screen the CID and CIU energy landscape for protein complexes as a function 
of charge state, IM drift time data was monitored to determine the minimum collision energy at 
which CIU is observed. Based on previous studies, the CIU energy threshold is defined as that 
energy at which a 2.5% increase in drift time/CCS relative to the smallest recorded value is 
observed (see Chapter 3). Figure 4-3a shows CCS values extracted from IM drift time data for 7+ 
β-Lac dimer ions over an acceleration voltage range of 20 to 200V. We observe protein complex 
compaction with no observable unfolding over the energy range attainable. From this same data, 
protein complex CID can be monitored, and is shown in Figure 4-3b. As accelerating voltage 
used to active the ions is increased, we observe the relative intensity of the 7+ dimer ion decrease 
while signals corresponding to the 3+ and 4+ monomer ions increase. At an accelerating voltage 
of 200 V, where we observe no precursor ion CIU, monomers account for more than 50% of the 
total ion intensity, indicating the CID threshold energy has been surpassed. Similar data was 
acquired for a range of protein complexes, including: β-Gal tetramer, β-Lac dimer, ConA 
tetramer, Hgb dimer and tetramer, SAP pentamer, and TPI dimer.  
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Figure 4-3. Representative data for β-lactaglobulin used to determine the charge state where CID and 
CIU threshold energies converge, and plots of all identified charge states from CID-CIU convergence 
screen. For 7+ β-lactaglobulin the (a) CCS data show compaction consistent with other studies and no 
unfolding over the full energy range of the instrument, while (b) mass spectra for different collision 
energies show the onset of monomer dissociation approximately 175 V. At 200 V, the monomer ion 
intensity accounts for more than 50% of the total ion intensity, indicating that the collision energy has 
exceeded the CID threshold energy. (c) Plot of log Protein Charge State verse log Protein Mass 
showing the linearity of the data for over mass range of 429 kDa (β-Lac (37 kDa) to β-Gal (466 kDa). 
(d) Plot of Predicted Protein Charge States generated from equation found in (c) verse Observed 
Protein Charge States. This plot also shows good linearity between theoretical charge states and 
measured charge states in a near one-to-one relationship. β-galactosidase data (open circle in c and d) 
is highlighted since at the CID threshold generated product ions associated with monomer backbone 
cleavage of up to 300 residues. 	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These data were combined with the threshold energies previously determined for avidin 
and aldolase tetramers (Chapter 3) and for tetrameric transthyretin (TTR).29 The identified 
charge states required for compact monomer ejection were then plotted as the log(protein charge 
state) against the intact mass of the precursor ion, plotted as log(protein mass), from the expected 
oligomer mass taken from the protein data bank (PDB), and the resultant plot is shown in Figure 
4-3c. This plot is highly linear, with an R2 of 0.9892. From these data, the charge state required 
for compact protein monomer ejection from its precursor assembly in the gas phase can be 
predicted using the following equation: 
 𝐶𝑆 = 0.012𝑀!.!" (1) 
where M is the expected sequence mass of the protein complex. In Figure 4-3d, we use this 
equation to predict the charge state required for onset of the compact monomer CID pathway, 
and compare these predicted charge states to those determined experimentally. A one-to-one 
relationship is observed, exhibiting good agreement to a linear fit (R2 = 0.9922), further 
supporting the predictive strength of Equation 1. 
 In order to evaluate the structure-relevant information content of the CID products 
generated via the compact monomer ejection pathway, we recorded CCS data for monomer 
product ions generated from the protein complex precursor charge states reported in Figure 4-3c 
and d. The analysis of this data is shown in Figure 4-4 for the following precursor ions: 7+ β-Lac 
dimer (a), 10+ TPI (b), 7+ Hgb dimer (c – Hgb A and d – Hgb B, open circles), 11+ Hgb tetramer 
(c and d, closed circles), 11+ avidin (e), 15+ ConA (f), 17+ SAP (g), and 19+ aldolase (h). Dashed 
lines on each plot indicated the theoretical CCS value predicted from the monomer extracted 
from the X-ray structure, as described previously.34 In cases where more symmetric charge 
partitioning is observed, measured CCS values are smaller than those predicted (see Fig. 4-4a, c,  
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Figure 4-4. Monomer collision cross-sections for (a) β-lactaglobulin, (b) triosephosphate isomerase, 
(c) hemoglobin A, (d) hemoglobin B, (e) avidin, (f) concanavalin A, (g) serum amyloid P, and (h) 
aldolase. For hemoglobin, monomers were generated from dimers (open circles) and tetramers (closed 
circles). Dashed lines correspond to predicted CCS values from known oligomer crystal structures. In 
cases where measured CCS values correlate well with or are much lower than predicted values (a, c, d, 
e, h), dissociation proceeds via a symmetric charge partitioning pathways. While in cases where 
measured CCS values are larger than predicted values (b, c, d, f, g), dissociation proceeds via an 
asymmetric charge partitioning pathways 	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d, e, and h), however in cases where charge partitioning with highly asymmetric, the measured 
CCS values are greater than those predicted (see Fig. 4-4b, c, d, f, and g), with the lowest charge 
state ions usually producing CCS measurements in closest agreement with theory. It is worth 
noting that, in cases where asymmetric charge partitioning-type CID was observed, the highest 
product ion charge state often exceeds the parent ion charge, supporting a charge reduction 
mechanism that includes direct anion attachment to the precursor ion, thus facilitating facile 
charge stripping following collissional activation.35 
4.3.3 Alternative Dissociation Pathways 
Data for β-Gal is highlighted in Figure 4-3c (open circle), as dissociation from compact states did 
not produce monomer ions. CID of low charge state precursor ions generate product ions that are 
related to covalent bond fragmentation and peptide product ions.29 As shown in Figure 4-5a, CID 
of the 35+ charge state produces product ions with a measured mass of 34800 ± 80 Da that is 
identified as a species produced from monomer backbone dissociation. Based on mass, we 
believe this product ion is likely a result of monomer backbone cleavage of around 300 residues 
(1021 total residues per monomer). In comparison to the dissociation products from 47+ β-Gal, 
shown in Figure 4-5b, we see that higher charge states also follow an alternative dissociation 
pathway, which has not been previously reported. This native charge state dissociation pathway 
is characterized by a bimodal product ion distribution where the two species have measured 
masses of 32870 ± 30 Da (similar to low charge state dissociation) and 47450 ± 30 Da. Relative 
to the intact monomer mass of β-Gal (117 kDa), we believe these two species to be monomer 
backbone cleavage products of approximately 300 and 400 residues, respectively. While 
dissociation of β-Gal does not follow the traditional pathway, the observed low charge state 
dissociation is consistent with native charge states. This data shows that low-charge state 
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dissociation from compact species can still be predicted from Equation 1, even if the pathway is 
 
Figure 4-5. Mass spectra produced from dissociation of (a) 35+ and (b) 47+ β-galactosidase. Insets 
show blown up regions of product species produced from dissociation. For 35+ β-Gal, dissociation 
produces a single species with a 17+ to 19+ charge distribution which has a measured mass of 34800 ± 
60 Da which is identified as product ions associated with monomer backbone cleavage of around 300 
residues. Similarly, for 47+ β-Gal, dissociation produces a two species with 19+ to 24+ and 21+ to 27+ 
charge distributions which have measured masses of 32870 ± 30 Da and 47450 ± 30 Da which are 
identified as product ions associated with monomer backbone cleavage of around 300 and 400 
residues, respectively.	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non-traditional. 
However, we did not observe catalase precursor ions of any charge state to release 
compact monomers. Instead, relatively low charge state precursor ions produced both unfolded 
monomer ions and heme-related product ions, as shown in the data for the 24+ tetramer (Figure 
4-6a). Similarly produced heme ions generated during CID of Hgb aid in identification of the 
616.2 m/z species as the traditional singly charged heme co-factor. However, rather than observe 
the traditional heme-oxygen peak at 632 m/z, 619.2 m/z and 635.2 m/z peaks corresponding to a 
3 Da shift of the heme and heme-O peaks are present. An additional peak, 648.2 m/z, is 
identified as heme-O2. The source of the 3 Da shift remains unknown, but is believed to be due 
to a relatively high abidance of an unidentified isotope. When compared to 33+ tetramer (Figure 
4-6b), dissociation also produces low-intensity monomer peaks and the same four heme-related 
peaks. Additionally, a high-intensity distribution of low-mass peaks was observed with a mass of 
approximately 19.5 kDa, which can be identified as monomer backbone cleavage of 
approximately one-third the intact monomer mass. A fourth low-intensity, high-mass distribution 
is also observed with a measured mass of approximately 214 kDa, identified as trimer bound to 
approximately two-thirds of the monomer. This is direct evidence of backbone cleavage 
occurring from the intact, unfolded tetramer, not a secondary dissociation event. It is worth 
noting that catalase and β-Gal are the two largest protein complexes included in this study. As 
such, caution should be taken when attempting to extrapolate the trends observed here toward 
large protein systems, especially when such systems contain co-factors and non-protein binding 
partners.  
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Figure 6-6. Mass spectra produced from dissociation of (a) 24+ and (b) 33+ catalase. Insets show 
blown up regions of product species produced from dissociation. For 24+ catalase, dissociation 
produces two types of species. Monomers are produced with a charge state distribution ranging from 
11+ to 14+. A second set of peaks in the low mass-to-charge region is observed with m/z values of 
616.2 m/z, 619.2 m/z, 635.2 m/z, and 648.2 m/z. The 616.2 m/z species is identified as the singly 
charged heme co-factor. 619.2 m/z and 635.2 m/z peaks correspond to a 3 Da shift of traditional heme 
and heme-O peaks, while the 648.2 m/z peak can be identified as heme-O2. The source of the 3 Da 
shift remains unknown. For 33+ catalase, in addition to the same heme-associated peaks and low-
intensity monomer peaks (with a charge state distribution ranging from 13+ to 16+), there are two 
additional distributions with charge distributions ranging from 13+ to 15+ and 17+ to 21+, which have 
measured masses of approximately 19.5 kDa and 214 kDa, respectively. The former distribution is 
identified as product ions associated with backbone cleavage of approximately one-third of the 
monomer while the latter distribution is identified as the complementary product ions, trimer bound to 
two-thirds of the monomer. 	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4.4 Conclusions 
Here, we have evaluated a CDP device as an effective method for generating lower 
charge states across a broad range of intact protein complexes under equivalent conditions. 
Following a detailed evaluation of the operation of the CDP device, we then utilized its ability to 
quickly produce large numbers of charge reduced protein ion signals to study the consequences 
of such charge reduced states on the CID pathway of intact protein complex ions.  The low 
charge states produced were screened to identify those charge states for which the dissociation 
and unfolding threshold energies converge to the same value or invert to produce product ions 
before the onset of unfolding. The identified charge states show that CID-CIU convergence can 
be predicted to a high degree of accuracy based on precursor mass alone over a mass range of 
approximately 429 kDa. The product ions were largely compact, but also included minor 
products in the forms of unfolded monomers, large peptide fragment ions, and protein co-factor 
release as a charged product. All of these product ions have been reported previously in the 
literature from protein complex precursor ions,29,36 however, the preferential appearance of large 
protein ions produced from backbone cleavage from both low and native charge state precursor 
ions of β-Gal and catalase has not, and may pose a limitation for charge reduction protocols that 
seek compact protein product ions exclusively if other such dissociation pathways are observed. 
We also observe enhanced charge stripping following the collisional activation of charge reduced 
protein complex ions produced using the CDP source, which clearly points to a direct anion 
attachment mechanism for CDP protein charge reduction.    
 The work presented here builds substantially on previous data for charge reduced protein 
complex ions and their CID product ions.  The predictive relationship presented in Equation 1 
represents a potentially useful framework for high-throughput structural biology protocols, 
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where monomer size information is often difficult to recover from solution disruption 
experiments alone.  The size information recorded for these monomers suggests a range of 
values for each monomer ejection, whereas both the average and the lowest CCS values for each 
dataset may, in many cases, provide a good starting point from which to evaluate the data in the 
structural biology content for protein complex topology modeling efforts.  Future work will be 
focused on broadening the available dataset of charge reduced protein CID data to include a 
greater number of large protein complexes that contain non-protein binding components and 
post-translational modifications, in order to more completely evaluate the breadth of the 
correlations provided in this report.   
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Chapter 5. Conclusions and Future Directions 
5.1 Conclusions 
IM-MS as a structural biology tool has proven its usefulness for assessing multiprotein complex 
topologies, and when incorporated with complementary datasets and modeling has the potential 
to generate model structures at the atomic level.1-5 However, in order to fully utilize IM-MS, 
complexes, subcomplexes, and individual subunits must be measured with retained native-like 
conformations in the gas phase, with the greatest challenge being the study of subunits and 
subcomplexes. Current methods for generating subunits and subcomplexes in solution require 
extensive screening of various solvent conditions in order to disrupt the complex while retaining 
substructural information.6 Alternatively, gas-phase dissociation using CID of charge reduced 
protein complexes has demonstrated that compact subunit conformations can be retained,7 
however, altering solution conditions runs the risk of altering complex structure before entering 
the gas phase, and the mechanism for compact dissociation is not fully understood. 
 Here we have demonstrated that using gas-phase ion-neutral chemistry compact native-
like conformations can be retained in the gas phase (Chapter 2). Furthermore, this method has 
demonstrated the ability to charge reduce species that would otherwise be too fragile to charge 
reduce using even the gentlest solution based charge reduction conditions (Appendix A). 
Therefore, gas-phase charge reduction approaches have demonstrated an ability to preserve gas-
phase structures by minimizing analyte interactions with charge reducing agents and maintaining 
optimal solution conditions for native MS. 
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 By studying the CID pathway of charge reduced states of aldolase and avidin using 
altered buffer conditions, we have discovered both species undergo structural rearrangements in 
the gas phase (Chapter 3). Aldolase undergoes a compaction of the tetramer before dissociation, 
consistent with other charge reduced species.8 While avidin also undergo compaction, it is not 
observed by IM-MS but through compacted product monomers, with collision cross-sections 
much smaller than the theoretical monomer size calculated from the crystal structure. These 
latter observations demonstrate evidence of structural rearrangement during dissociation since 
monomer CCS values decrease while the tetramer CCS remains constant. Additional evidence of 
a structural rearrangement is found in the avidin product trimer CCS values, which are also much 
smaller than the theoretical size from a scaled projection approximation. 
 A corona discharge probe similar to the one built by Campuzano and Schnier9 was used 
to probe charge states across a range of proteins to identify the charge state at which the CID 
threshold energy is lower than the CIU threshold energy (Chapter 4). The ion-ion gas-phase 
charge reduction approach here proved to be advantageous since broad CSDs were observed 
with high levels of charge reduction all under the same charge reduction conditions. It was 
discovered that the charge state can be predicted by analyte mass through a simple exponential 
relationship, similar to the relationship of mass to expected charge state from native MS 
conditions discovered by de la Mora.10 This relationship is consistent for oligomer protein 
complexes covering more than a decade of mass space. The ability to predict when dissociation 
will occur prior to unfolding is essential for using this charge reduced CID pathway as a tool for 
producing and measuring subunits and subcomplexes from an uncharacterized multiprotein 
complex in the gas phase for purposes of building model structures; however, using this method 
as a tool must be done with caution, as experimental evidence has shown both cases where 
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product monomer ions are mush larger and much smaller than predicted crystal structure 
monomers sizes. We have demonstrated the ability to generate the necessary charge states via 
two gas-phase charge reduction approaches and we have shown predictability in the charge state 
at which dissociation and unfolding energies converge, but there is still the question of the 
methods effect on gas-phase structure. We have observed two distinct pathways in the 
dissociation of low charge state multiprotein complexes and have been able to model these new 
gas-phase structures. What we do not understand is why these two proteins behave so differently, 
the effect is likely due to differences in inter-protein interactions as other variables have been 
screened (mass, stoichiometry, secondary and tertiary structure). Furthermore, the absence of 
compaction is the exception, not the rule. Understanding what makes these proteins behave 
differently is essential for using this method as a tool for structural biology. 
5.2 Future Directions 
Understanding why some protein complexes behave differently during dissociation than others at 
low charge states we be a valuable analytical tool, since we will be able to categorize a particular 
protein based on a single metric. Furthermore, once we can accurately correct for gas-phase 
compaction of subunits and subcomplexes during dissociation, this technique will be essential 
for screening the unknown structure of key biological targets. This broadly applicable technique 
has proven its ability to measure subunit sizes, and in come cases subcomplexes. Additionally, 
we are not limited to only studying complete multiprotein complex assemblies; the gas-phase 
charge reduction techniques presented here can easily be applied to studying subcomplexes 
generated through solution disruption conditions. Essentially, it will act as a complementary 
technique to other more traditional methods of subunit generation by extending the range of 
measureable subunits when traditional solution methodologies disrupt native conformations. In 
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the short-term, some key questions remain in order to optimize charge reduction conditions and 
correlate experiments to theoretical structures, but the long-term implication of the technique in 
the field of structural biology is promising. IM-MS is a quickly developing structural biology 
tool, and with this added technique its range of applications is even greater.  
5.2.1 Alternative Charge Reducing Agents 
The gas-phase ion-neutral charge reduction presented here has been focused on charge reduction 
using the charge reducing agent 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU).11 However, many 
different charge reducing agents exist that have not been studied in the gas phase.12,13 The 
structures and gas-phase basicities of four charge reducing agents are shown in Figure 5-1. While 
some of these reagents have been tested in the gas phase via introduction from the nebulizing 
 
Figure 5-1. Structures and gas-phase basicities for (a) 1,5,7-triazabicyclo[4.4.0]dec-5-ene, (b) 1,5-
diazabicyclo[4.3.0]non-5-ene, (c) 1,1,3,3-tetramethyl guanidine, and (d) triethylamine. All four of 
these basic species have been used, and proven effective, as solution additives for charge reduction, 
and should be extensively tested as gas-phase ion-neutral charge reduction reagents. 
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sprayer (DBN and TEA), they have not been screened for structural retention/effects in the gas 
phase. Of additional interest for introduction via nebulizer spray are various neutral buffers 
known to cause charge reduction as an alternative solvent,12,14 as well as strong bases, such as 
piperidine, which have been shown to be effective gas-phase charge reducing agents when 
seeded in gases.15 
5.2.2 Redesigned Corona Discharge Probe 
The current design of the corona discharge probe utilizes gas flow parallel to the point-to-plane 
geometry in order to push generated anions out through an aperture in the plate.9 A cross-section 
of a redesigned probe with the point-to-plane geometry perpendicular to the gas-flow is shown in 
Figure 5-2. This design improves upon the previous design in that the gas flow path is more open 
allowing for better disbursement of anions. Additionally, the new position of the point-to-plane 
geometry allows for better control of the point-to-plane distance and allows for the 
implementation of a Faraday cage, as was used in the earliest experiments with corona discharge 
charge reduction, to remove electric field effects within the source region.16,17 Other experiments 
utilizing corona discharge charge reduction contained within source regions have demonstrated 
the reduced adduction by seeding the nitrogen gas with methanol.18 Testing the effect of 
methanol, and other volatile organic solvents, with both the current CDP design and this new 
design could be advantageous as extensive adduction was observed throughout these current 
studies. Using alternative gases may also change the observed charge reduction as different 
anions may interact differently in the gas phase than current anions generated from nitrogen.19 
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5.2.3 Gas-Phase Supercharging 
Ion-neutral charge reduction was performed here to preserve native-like gas-phase 
conformation.11 Use of supercharging agents in solution has demonstrated that multiprotein 
complex structures are disrupted in solution due to these supercharging agents.20,21 Recently, a 
gas-phase ion-neutral supercharging approach has been demonstrated by seeding curtain gas with 
acid vapor.22 Conventional supercharging agents, such as sulfolane and m-nitrobenzyl alcohol 
(m-NBA), can be implemented for gas-phase supercharging through use of the nebulizing 
sprayer to preserve native-like conformations at high charge states.23,24 Additionally, the sprayer 
could be used to introduce low concentration acids from volatile solvents. The desire for 
generating higher charge states of multiprotein complexes is motivated by the fact that higher 
Figure 5-2. Cross-section of redesigned corona discharge probe with added Faraday cage and point-
to-plane geometry positioned perpendicular to gas flow. Gas carrying anions exit through a larger 
opening, which will potentially allow for better disbursement of anions. The Faraday cage is employed 
to remove electric field effects in the source, in order to improve analyte ion transmission. The 
reorientated point-to-plane geometry also allows for better visual control over the point-to-plane 
distance.	  
 105 
charge states have been observed to produce peptide fragments similar to top-down techniques 
following the traditional unfolding and dissociation.25 
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Appendix A: Chapter 2 Supporting Information
 
Figure A-1.  Mass spectra for concanavalin A under control conditions (bottom), under solution additive 
charge reduction conditions with DBU (middle), and under gas-phase charge reduction conditions with 
DBU (top).  Concanavalin A exits in equilibrium as tetramer (   ), dimer (   ), and monomer (   ).  In 
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solution additive charge reduction, dissociation of the tetramer into dimer and monomer is observed, 
while with gas-phase charge reduction approaches the tetramer structure is retained. 
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Appendix B: Protocol for Nebulizing Sprayer Operation 
The following section contains detailed information for operation of the nebulizing sprayer for 
charge reduction. 
Preparation 
1. Make base solution to desired concentration. From trial and error, a 10% base solution is 
a good starting concentration as it induces charge reduction, but is not so high where 
signal will be completely neutralized. Experimental evidence shows that base 
concentration will determine the level of charge reduction. 
2. Base flow rate will be high and droplets will accumulate in the source. Be sure to line 
bottom of source housing with disposable absorbent material such as paper towel or 
pigmat. 
3. Nebulizer can be positioned orthogonal to source cone, as shown in Figure 2-1, or 
positioned in-line with source cone, similar to CDP orientation (see Chapter 4). It is 
important that base is not sprayed directly into the cone. In in-line orientation, sprayer 
should be aligned off-axis; directing the sprayer down and to the left of the cone orifice 
has proven effect, to prevent effecting other elements in the source cover as much of the 
cone and surrounding source block as possible with parafilm. In the orthogonal 
orientation, the sprayer is mounted on an adjustable stage, ensure position of stage does 
not allow spray to directly enter the cone. 
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4. Attach gas line to sprayer. Load 10 mL syringe with prepared base solution. Ensure 
syringe pump is setup for 10 mL syringe, load syringe, and attach tubing via syringe 
connector, ensure connector is snug. 
5. Begin syringe pump with gas turned off at the flow rate to be used for charge reduction. 
This is done to load the capillary with base solution, higher flow rates cannot be used 
since backing pressure at high flow rates will cause syringe to disconnect from tubing. 
Operation 
1. Ensure good MS signal before turning on nebulizer. 
2. Begin syringe pump and gas flow, typical base flow rates range from 5-25 mL/hr, with 10 
mL/hr utilized most often. Gas flow is operated at a pressure ranging from 20-35 psi, 
with 10 psi utilized when a 10 mL/hr flow rate is used. The gas pressure must be adjusted 
to ensure nebulization at the selecting flow rate. At higher flow rates, higher gas pressure 
must be used. This can be determined visually, if gas pressure is too low droplets will 
form at the end of the capillary. 
3. Adjust nebulizer position to ensure nebulized droplets interact with the electrospray 
plume. If this is not done, base droplets do not interact with charged electrospray droplets 
and charge reduction is not observed. 
Clean-up 
1. Flush syringe and tubing with a 50:50 methanol:water solution by running syringe pump 
and standard flow rates, again due to high backing pressure at high flow rates. This is 
critical since the water in the base solution will evaporate leaving concentrated base that 
will clog the tubing and capillary. 
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2. The source region must be thoroughly cleaned as any residual base with cause mild 
charge reduction. Clean the cone following standard protocol using 10% acetic acid, 
followed by methanol wash. Wipe down any surfaces that may have come into contact 
with base using methanol:water solution. 
3. Dispose of any base contaminated paper towel or pigmats appropriately. 
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Appendix C: Chapter 3 Supporting Information 
 
Figure C-1. Aldolase collision induced unfolding fingerprints for measured native and charge reduced 
charge states. 
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Figure C-2. Avidin collision induced unfolding fingerprints for measured native and charge reduced 
charge states. 
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Table C-1. Coarse grain avidin model structures generated during Monte Carlo search. Measured 
experimental CCS, calculated model CCS, and calculated spherical overlap are given for each model. A 
minimum 15% overlap indicates good subunit interaction. Tetramer models shown are the model in best 
agreement with CCS data and the model with a 15% minimum spherical overlap with a CCS closest to 
the experimental value. 
 
 
115	  
	  
Appendix D: Chapter 4 Supporting Information 
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Figure D-1. Avidin mass spectra with and without corona discharge charge reduction. 
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Figure D-2. Aldolase mass spectra with and without corona discharge charge reduction. 
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Figure D-3. Concanavalin A mass spectra with and without corona discharge charge reduction. 
119	  
	  
 
Figure D-4. Alcohol dehydrogenase mass spectra with and without corona discharge charge reduction. 
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Figure D-5. Pyruvate kinase mass spectra with and without corona discharge charge reduction. 
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Figure D-6. Glutamate dehydrogenase mass spectra with and without corona discharge charge reduction. 
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Figure D-7. Avidin CIU fingerprints generated from the 12+ ion with solution based charge reduction 
and corona discharge charge reduction. 
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Table D-1. Measured CCS values for each observed charge state of β-Lac dimer, TPI, SAP, and β-Gal 
under control and CDP charge reduction. Charge states denoted with a star (∗) were observed in the mass 
spectrum but has low drift time intensity, preventing CCS measurement. 
	  	     Measured CCS (Å2) 
	  	  
 
b-Lac dimer TPI SAP b-Gal 
	  	     Control CDP Control CDP Control CDP Control CDP 
O
lig
om
er
 C
ha
rg
e 
St
at
e 
4+   *             
5+   *             
6+   2223             
7+   2301             
8+   2376   2801         
9+   2385   2896         
10+   2551   2986         
11+ 2625 2623   3074   *     
12+ 2723 2731   3159   *     
13+ 2848   3236 3244   5821     
14+     3316 3328   5859     
15+     3382 3422   5906     
16+     3496 3542   5998     
17+           6088     
18+           6155     
19+           6244     
20+           6290     
21+           6380     
22+         6496 6437     
23+         6580 6568     
24+         6600 6620     
25+         6658 6704     
26+         6687 6765     
27+         6774       
28+         6887       
29+                 
30+                 
31+                 
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32+                 
33+                 
34+                 
35+                 
36+               * 
37+               17306 
38+               17368 
39+               17580 
40+               17471 
41+               17435 
42+               17494 
43+               17621 
44+             * 17726 
45+             17810 17646 
46+             17981 17637 
47+             17565 17780 
48+             17520 17779 
49+             17544 17681 
50+             17543 17688 
51+             17591 17668 
52+             17620 17699 
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Appendix E: Protocol for Corona Discharge Probe Operation 
The following section contains detailed information for operation of the corona discharge probe 
for charge reduction. 
Preparation 
1. Clean stainless steel plate by washing in sonicator for 30 minutes in 10% acetic acid, 
followed by a 20 minute wash in water, followed by a final 20 minute wash in methanol. 
It is essential that the plate be clean, longer washings have shown improved performance. 
2. The platinum wire needs to be ground to a fine point. This is best done fresh each day by 
first using a Dremel Rotary Tool to clean the wire and create a rough point. Next using 
fine grit sandpaper, the rough point should be smoothed to a clean point under a 
microscope. 
3. Assemble probe (see Chapter 4). Point-to-plane distance should be 1.5-2.5 mm, with 2 
mm most commonly used. FOR SAFETY: ensure stainless steel plate is grounded. If it is 
not grounded, discharge will occur with the steel tube. This will put a high voltage 
current through the source housing. 
4. Turn on power supply and look for corona discharge, visible as a faint purple light. If 
point-to-plane distance is too small, current will be too high and circuit breaker will trip. 
If distance is too large, no corona discharge will be observed, or discharge will occur 
with stainless steel tube. 
5. Position probe with plate approximately 1.5 cm from sample cone orifice, with plate 
aperture directed to the right of the cone. Positioning probe directly in-line with orifice or 
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to left of orifice (toward ESI emitter) prevents ions from traversing the ‘Z’ orientation of 
the source due to high ion velocities produced by the high gas flow rate. 
Operation 
1. Before charge reducing analyte, optimize probe and ESI emitter positions using 
denatured CytC. Ensure good signal intensity before turning on CDP. 
2. Increase sampling cone voltage to 200 V. For intact protein complexes, decrease backing 
pressure to ~7 mbar. 
3. Turn on nitrogen gas flow. Gas pressure can range from 60-100 psi, with 70 psi most 
commonly used. 
4. Turn on power supply. Voltages can range from 6500-8500 V, with 7250 V most 
commonly used. 
5. Using CytC, adjust CDP position and ESI emitter position for optimized charge 
reduction. Ensure 3+, and low level 2+, charge states are observed. 
6. Using same CDP and ESI emitter positions from CytC, charge reduce analyte. Slight 
adjustment to ESI emitter position may be necessary to ensure good signal intensity. 
7. For performing unfolding experiments on intact protein complexes, it is necessary to 
increase the trap gas flow rate. Flow rate is typically operated at 7 mL/min, up from 5 
mL/min. 
